| For: | Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015; 21(37): 10609-10620 [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i37/10609.htm |
| Number | Citing Articles |
| 1 |
Adrian L Lopresti. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?. Advances in Nutrition 2018; 9(1) doi: 10.1093/advances/nmx011
|
| 2 |
Rad Ghannadzadeh Kermani pour, Sara Kamali Zounouzi, Melina Farshbafnadi, Nima Rezaei. The interplay between gut microbiota composition and dementia. Reviews in the Neurosciences 2025; 36(5) doi: 10.1515/revneuro-2024-0113
|
| 3 |
Morgane Linard, Alix Ravier, Louisa Mougué, Iris Grgurina, Anne‐Laurence Boutillier, Alexandra Foubert‐Samier, Frédéric Blanc, Catherine Helmer. Infectious Agents as Potential Drivers of α‐Synucleinopathies. Movement Disorders 2022; 37(3) doi: 10.1002/mds.28925
|
| 4 |
Sara Gerhardt, M. Hasan Mohajeri. Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases. Nutrients 2018; 10(6) doi: 10.3390/nu10060708
|
| 5 |
Imanuel Lerman, Yifeng Bu, Rahul Singh, Harold A. Silverman, Anuj Bhardwaj, Alex J. Mann, Alik Widge, Joseph Palin, Christopher Puleo, Hubert Lim. Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation. Bioelectronic Medicine 2025; 11(1) doi: 10.1186/s42234-024-00163-4
|
| 6 |
Surya Sudheer, Prateeksha Gangwar, Zeba Usmani, Minaxi Sharma, Vivek Kumar Sharma, Siva Sankar Sana, Fausto Almeida, Nawal Kishore Dubey, Dhananjaya Pratap Singh, Neeraj Dilbaghi, Hamid Reza Khayat Kashani, Vijai Kumar Gupta, Brahma Nand Singh, Maryam Khayatkashani, Seyed Mohammad Nabavi. Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases. Biochimie 2022; 193 doi: 10.1016/j.biochi.2021.10.010
|
| 7 |
Mami Sato, Rieko Arakaki, Hiroaki Tawara, Takaaki Tsunematsu, Naozumi Ishimaru. Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice. International Journal of Molecular Sciences 2021; 22(6) doi: 10.3390/ijms22063239
|
| 8 |
Xue Xiong, Yin-Zhi Xu, Yan Zhang, Hong-Fei Zhang, Tian-Min Dou, Xing-Yu Li, Zhao-Yuan Xu, Chang-Peng Cui, Xue-Lian Li, Bai-Yan Li. Renalase Overexpression-Mediated Excessive Metabolism of Peripheral Dopamine, DOPAL Accumulation, and α-Synuclein Aggregation in Baroreflex Afferents Contribute to Neuronal Degeneration and Autonomic Dysfunction. Biomedicines 2025; 13(5) doi: 10.3390/biomedicines13051243
|
| 9 |
Yewei Qu, Peiru Wang, Dongjie Wang, Bo Li, Fan Yang. Intermittent fasting protects MPTP-induced Parkinson's disease mouse model through regulating gut microbiota dysbiosis. International Immunopharmacology 2026; 175 doi: 10.1016/j.intimp.2026.116447
|
| 10 |
Yuan Feng, Kaixiao Wang, Xulong Guo, Huijie Guo, Xiaoya Gao. Bibliometric analysis of the pathogenesis of Parkinson's Disease. Pathology - Research and Practice 2026; 281 doi: 10.1016/j.prp.2026.156417
|
| 11 |
Haitian Nan, Takahiro Natori, Yuta Ichinose, Kishin Koh, Yoshihisa Takiyama. Conjugal multiple system atrophy: Computing chance or investigating real patients?. Parkinsonism & Related Disorders 2020; 75 doi: 10.1016/j.parkreldis.2020.03.005
|
| 12 |
Arianna Polverino, Pierpaolo Sorrentino, Matteo Pesoli, Laura Mandolesi. Nutrition and cognition across the lifetime: an overview on epigenetic mechanisms. AIMS Neuroscience 2021; 8(4) doi: 10.3934/Neuroscience.2021024
|
| 13 |
Valeria D. Felice, Eamonn M. Quigley, Aideen M. Sullivan, Gerard W. O'Keeffe, Siobhain M. O'Mahony. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism & Related Disorders 2016; 27 doi: 10.1016/j.parkreldis.2016.03.012
|
| 14 |
THE GUT-BRAIN AXIS IN NEURODEGENERATIVE DISEASES AND MOOD DISORDERS: MECHANISMS AND SCIENTIFIC EVIDENCE. International Journal of Innovative Technologies in Social Science 2025; (4(48)) doi: 10.31435/ijitss.4(48).2025.4431
|
| 15 |
Taiwo G. Olubodun-Obadun, Ismail O. Ishola, Olufunmilayo O. Adeyemi. Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease. Drug Metabolism and Personalized Therapy 2022; 37(4) doi: 10.1515/dmpt-2021-0144
|
| 16 |
Gianfranco Natale, Larisa Ryskalin, Gabriele Morucci, Gloria Lazzeri, Alessandro Frati, Francesco Fornai. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease. Life 2021; 11(8) doi: 10.3390/life11080732
|
| 17 |
Hamed Mirzaei, Saman Sedighi, Ebrahim Kouchaki, Erfaneh Barati, Ehsan Dadgostar, Michael Aschner, Omid Reza Tamtaji. Probiotics and the Treatment of Parkinson's Disease: An Update. Cellular and Molecular Neurobiology 2022; 42(8) doi: 10.1007/s10571-021-01128-w
|
| 18 |
Shen-Yuan Zheng, Hai-Xia Li, Rui-Chen Xu, Wen-Teng Miao, Ming-Yuan Dai, Song-Tao Ding, Han-Deng Liu. Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Research Reviews 2021; 69 doi: 10.1016/j.arr.2021.101347
|
| 19 |
James K. Ruffle, Steven J. Coen, Vincent Giampietro, Steven C.R. Williams, A. Vania Apkarian, Adam D. Farmer, Qasim Aziz. Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans. Human Brain Mapping 2018; 39(1) doi: 10.1002/hbm.23850
|
| 20 |
Ingar Olsen, Douglas B. Kell, Etheresia Pretorius. Is Porphyromonas gingivalis involved in Parkinson’s disease?. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(11) doi: 10.1007/s10096-020-03944-2
|
| 21 |
Eliseu da Cruz Moreira-Junior. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease. Medical Hypotheses 2019; 133 doi: 10.1016/j.mehy.2019.109399
|
| 22 |
Steven P. Mathis, Sobha R. Bodduluri, Bodduluri Haribabu. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(9) doi: 10.1016/j.bbalip.2021.158982
|
| 23 |
Arun T Nair, Vadivelan Ramachandran, Nanjan M Joghee, Shanish Antony, Gopalakrishnan Ramalingam. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. Journal of Neurogastroenterology and Motility 2018; 24(1) doi: 10.5056/jnm17105
|
| 24 |
Chunxiao Li, Li Cui, Yimin Yang, Jing Miao, Xiuzhen Zhao, Jingdian Zhang, Guohong Cui, Ying Zhang. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China. Frontiers in Molecular Neuroscience 2019; 12 doi: 10.3389/fnmol.2019.00171
|
| 25 |
Büin Adams, J. Massimo Nunes, Martin J. Page, Timothy Roberts, Jonathan Carr, Theo A. Nell, Douglas B. Kell, Etheresia Pretorius. Parkinson’s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens. Frontiers in Aging Neuroscience 2019; 11 doi: 10.3389/fnagi.2019.00210
|
| 26 |
Anna D. Holmes, Julia Spoendlin, Anna L. Chien, Hilary Baldwin, Anne Lynn S. Chang. Evidence-based update on rosacea comorbidities and their common physiologic pathways. Journal of the American Academy of Dermatology 2018; 78(1) doi: 10.1016/j.jaad.2017.07.055
|
| 27 |
Qingsen Shang, Ya Wang, Lin Pan, Qingfeng Niu, Chao Li, Hao Jiang, Chao Cai, Jiejie Hao, Guoyun Li, Guangli Yu. Dietary Polysaccharide from Enteromorpha Clathrata Modulates Gut Microbiota and Promotes the Growth of Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp.. Marine Drugs 2018; 16(5) doi: 10.3390/md16050167
|
| 28 |
Jae-Hwan Jang, Mi-Jung Yeom, Sora Ahn, Ju-Young Oh, Suhwan Ji, Tae-Hong Kim, Hi-Joon Park. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson’s disease. Brain, Behavior, and Immunity 2020; 89 doi: 10.1016/j.bbi.2020.08.015
|
| 29 |
Guilian Yang, Yanlong Jiang, Wentao Yang, Fang Du, Yunbao Yao, Chunwei Shi, Chunfeng Wang. Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide. Microbial Cell Factories 2015; 14(1) doi: 10.1186/s12934-015-0394-2
|
| 30 |
Charul Rajput, Alika Sarkar, Nidhi Sachan, Neeraj Rawat, Mahendra Pratap Singh. Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?. Neurochemical Research 2021; 46(3) doi: 10.1007/s11064-020-03187-9
|
| 31 |
Sebastian Dohm-Hansen, Francisco Donoso, Paul J. Lucassen, Gerard Clarke, Yvonne M. Nolan. The gut microbiome and adult hippocampal neurogenesis: A new focal point for epilepsy?. Neurobiology of Disease 2022; 170 doi: 10.1016/j.nbd.2022.105746
|
| 32 |
Agnia Teterleva, Vladislav Abramov, Andrey Morgun, Irina Larionova, Michael Sadovsky. Bioinformatics and Biomedical Engineering. Lecture Notes in Computer Science 2022; 13346 doi: 10.1007/978-3-031-07704-3_17
|
| 33 |
Monica Montagnani, Lucrezia Bottalico, Maria Assunta Potenza, Ioannis Alexandros Charitos, Skender Topi, Marica Colella, Luigi Santacroce. The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210322
|
| 34 |
Claudio Nazzi, Alessio Avenanti, Simone Battaglia. The Involvement of Antioxidants in Cognitive Decline and Neurodegeneration: Mens Sana in Corpore Sano. Antioxidants 2024; 13(6) doi: 10.3390/antiox13060701
|
| 35 |
Cristiana Vilela, Bruna Araújo, Carla Soares-Guedes, Rita Caridade-Silva, Joana Martins-Macedo, Catarina Teixeira, Eduardo D. Gomes, Cristina Prudêncio, Mónica Vieira, Fábio G. Teixeira. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?. Cells 2024; 13(9) doi: 10.3390/cells13090770
|
| 36 |
Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, Savanah Descôteaux, Maria-Grazia Martinoli. New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and
Neuroprotection. Current Pharmaceutical Design 2022; 28(37) doi: 10.2174/1381612828666220919085742
|
| 37 |
Yan Hong, Chang Ge, Jing Jin, Yifei Gao, Yan Tang. D-mannose alleviates rotenone-induced PD mouse model through microbiota-gut-brain axis. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-36272-0
|
| 38 |
Jialing Li, Danghan Xu, Yingyu Liu, Yang Cao, Jun He, Muxi Liao. Acupuncture Treatment of Guillain–Barré Syndrome After Using Immune Checkpoint Inhibitors: A Case Report. Frontiers in Neurology 2022; 13 doi: 10.3389/fneur.2022.908282
|
| 39 |
Xinyue Zhang, Yizhao Ma, Ge Gao, Qihui Wu. Aggregation and Propagation of α‐Synuclein in Parkinson's Disease: A Bibliometric Perspective. Brain and Behavior 2025; 15(11) doi: 10.1002/brb3.71023
|
| 40 |
Carolina Malagelada, Matteo Guarino, Elena Bonora, Lisa Lungaro, Giovanni Barbara, Vincenzo Stanghellini, Roberto De Giorgio. Clinical presentation, diagnosis and management of chronic intestinal and colonic pseudo-obstruction in neurological diseases. Autonomic Neuroscience 2026; 268 doi: 10.1016/j.autneu.2026.103473
|
| 41 |
Samantha Molsberry, Kjetil Bjornevik, Katherine C. Hughes, Brian Healy, Michael Schwarzschild, Alberto Ascherio. Diet pattern and prodromal features of Parkinson disease. Neurology 2020; 95(15) doi: 10.1212/WNL.0000000000010523
|
| 42 |
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov. The gut microbiome as a factor in the development of Parkinson's disease. Neurology, Neuropsychiatry, Psychosomatics 2023; 15(1) doi: 10.14412/2074-2711-2023-1-90-96
|
| 43 |
A. V. Stavrovskaya, V. N. Danilenko, D. N. Voronkov, A. S. Gushchina, M. V. Marsova, A. S. Olshansky, N. G. Yamshikova, S. N. Illarioshkin. Pharmabiotic Based on Lactobacillus fermentum Strain U-21 Modulates the Toxic Effect of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine as Parkinsonism Inducer in Mice. Human Physiology 2021; 47(8) doi: 10.1134/S0362119721080120
|
| 44 |
Garima Sharma, Monika Kadian, Kritika Sharma, Shivani Pandita, Kanishka Shrivasatava, Anil Kumar. Brain-Iron Cross Talk. Nutritional Neurosciences 2023; doi: 10.1007/978-981-19-7327-7_5
|
| 45 |
Mark H. Sundman, Nan-kuei Chen, Vignesh Subbian, Ying-hui Chou. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain, Behavior, and Immunity 2017; 66 doi: 10.1016/j.bbi.2017.05.009
|
| 46 |
Francisca Villavicencio-Tejo, Margrethe A. Olesen, Laura Navarro, Nancy Calisto, Cristian Iribarren, Katherine García, Gino Corsini, Rodrigo A. Quintanilla. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders. Neurotoxicity Research 2024; 42(1) doi: 10.1007/s12640-023-00681-0
|
| 47 |
Varruchi Sharma, Atul Sankhyan, Anshika Varshney, Renuka Choudhary, Anil K. Sharma. Current Paradigms to Explore the Gut Microbiota Linkage to Neurological Disorders. EMJ Neurology 2020; doi: 10.33590/emjneurol/20-00068
|
| 48 |
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, Elisa Pierella, Marcello Romeo, Giovanni Ricevuti, Marchesi Nicoletta, Salvatore Chirumbolo, Alessia Pascale. The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment. International Journal of Molecular Sciences 2022; 23(20) doi: 10.3390/ijms232012289
|
| 49 |
Sarah Jaehwa Park, Barış Erhan Özdinç, Kathryn Grace Coker, Dana M. Walsh, Devon J. Fox, Samantha Evans, Joshua Farahnik, Kelly Moffat, Margaret Boomgaarden, Laurie K. Mischley. Metagenomics indicates an interplay of the microbiome and functional pathways in Parkinson’s disease. npj Parkinson's Disease 2026; 12(1) doi: 10.1038/s41531-026-01271-5
|
| 50 |
Eamonn M.M. Quigley. Basic Definitions and Concepts: Organization of the Gut Microbiome. Gastroenterology Clinics of North America 2017; 46(1) doi: 10.1016/j.gtc.2016.09.002
|
| 51 |
Yanjun Shi, Lu Qin, Mengting Wu, Junyu Zheng, Tao Xie, Zhiyong Shao. Gut neuroendocrine signaling regulates synaptic assembly in C. elegans. The EMBO Reports 2022; 23(8) doi: 10.15252/embr.202153267
|
| 52 |
Rijan Bajracharya, Neil A. Youngson, J. William O. Ballard. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease. International Journal of Molecular Sciences 2019; 20(8) doi: 10.3390/ijms20081850
|
| 53 |
Gabriele Deidda, Manuele Biazzo. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Frontiers in Neuroscience 2021; 15 doi: 10.3389/fnins.2021.753915
|
| 54 |
Hui Wang, Feng Yang, Ruihua Xin, Dongan Cui, Jiongjie He, Shidong Zhang, Yan Sun. The gut microbiota attenuate neuroinflammation in manganese exposure by inhibiting cerebral NLRP3 inflammasome. Biomedicine & Pharmacotherapy 2020; 129 doi: 10.1016/j.biopha.2020.110449
|
| 55 |
Matthew C.L. Phillips, Deborah K.J. Murtagh, Linda J. Gilbertson, Fredrik J.S. Asztely, Christopher D.P. Lynch. Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial. Movement Disorders 2018; 33(8) doi: 10.1002/mds.27390
|
| 56 |
Tomislav Meštrović, Mario Matijašić, Mihaela Perić, Hana Čipčić Paljetak, Anja Barešić, Donatella Verbanac. The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. Diagnostics 2020; 11(1) doi: 10.3390/diagnostics11010007
|
| 57 |
M. Roy, M. Péré, P. Damier, S. Bruley des Varannes, P. Derkinderen, T. Rouaud. STW5 (Iberogast®) for constipation in Parkinson's disease. Revue Neurologique 2021; 177(3) doi: 10.1016/j.neurol.2020.06.005
|
| 58 |
Hong-Xing Wang, Yu-Ping Wang. Gut Microbiota-brain Axis. Chinese Medical Journal 2016; 129(19) doi: 10.4103/0366-6999.190667
|
| 59 |
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi, Chaiyavat Chaiyasut. Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review. Microorganisms 2022; 10(7) doi: 10.3390/microorganisms10071405
|
| 60 |
Ji Eun Kim, Ki Chun Kwon, You Jeong Jin, Ayun Seol, Hee Jin Song, Yu Jeong Roh, Tae Ryeol Kim, Eun Seo Park, Gi Ho Park, Ji Won Park, Young Suk Jung, Joon Yong Cho, Dae Youn Hwang. Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice. Laboratory Animal Research 2023; 39(1) doi: 10.1186/s42826-023-00181-4
|
| 61 |
Thiruppathi Govindhan, Leela Palanisamy, Sundararaj Palanisamy. Bacillus licheniformis as a Novel Therapeutic Approach for Huntington’s Disease in Caenorhabditis elegans. Indian Journal of Microbiology 2026; doi: 10.1007/s12088-026-01566-4
|
| 62 |
Genaro Gabriel Ortiz, Luis H. de, José A. Cruz-Serrano, Erandis D. Torres-Sánchez, Miriam A. Mora-Navarro, Daniela L. C. Delgado- Lara, Irma Gabriela Ortiz-Velázquez, Héctor González-Usigli, Oscar K. Bitzer-Quintero, Mario Mireles Ramírez. Eat, Learn, Remember. 2019; doi: 10.5772/intechopen.79493
|
| 63 |
Analysis of parkinson’s disease patients with Gastrointestinal symptoms using structural and functional magnetic resonance imaging. Brain Imaging and Behavior 2025; 19(6) doi: 10.1007/s11682-025-01057-y
|
| 64 |
Hanyu Zhu, Haijun He, Ming Yang, Hanbing Zhu, Akifumi Hagiwara, Liting Shu, Jiangxingzi Xu, Yufang Miao, Xiaowei Han, Chuanliu Wang. Artificial intelligence empowers gut microbiota research in neurodegenerative diseases molecular mechanisms and precision therapy. iScience 2025; 28(12) doi: 10.1016/j.isci.2025.114044
|
| 65 |
Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Research 2016; 1642 doi: 10.1016/j.brainres.2016.03.042
|
| 66 |
Rajnish Srivastava, Mandeep Kumar Gupta. Gut bacteria-derived metabolites and their implications in mental health and neurological diseases. World Journal of Microbiology and Biotechnology 2025; 41(11) doi: 10.1007/s11274-025-04656-5
|
| 67 |
Christine Tara Peterson. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. Journal of Evidence-Based Integrative Medicine 2020; 25 doi: 10.1177/2515690X20957225
|
| 68 |
Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das. Gut dysfunction in Parkinson's disease. World Journal of Gastroenterology 2016; 22(25): 5742-5752 doi: 10.3748/wjg.v22.i25.5742
|
| 69 |
E. Fernández-Espejo. Microorganisms associated with increased risk of Parkinson’s disease. Neurología (English Edition) 2023; 38(7) doi: 10.1016/j.nrleng.2020.08.023
|
| 70 |
Lisa M. Smith, Louise C. Parr‐Brownlie. A neuroscience perspective of the gut theory of Parkinson's disease. European Journal of Neuroscience 2019; 49(6) doi: 10.1111/ejn.13869
|
| 71 |
Adam Shute, Dominique G. Bihan, Ian A. Lewis, Yasmin Nasser. Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.917197
|
| 72 |
Yogesh Bhattarai, Purna C. Kashyap. Parkinson’s disease: Are gut microbes involved?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(5) doi: 10.1152/ajpgi.00058.2020
|
| 73 |
Mengting Luan, Jianing Jin, Ying Wang, Xiaoyuan Li, Anmu Xie. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neuroscience Letters 2022; 775 doi: 10.1016/j.neulet.2022.136547
|
| 74 |
Ling-Xiao Yi, Eng King Tan, Zhi Dong Zhou. The α-Synuclein Seeding Amplification Assay for Parkinson’s Disease. International Journal of Molecular Sciences 2025; 26(1) doi: 10.3390/ijms26010389
|
| 75 |
Melissa Scholefield, Stephanie J. Church, Jingshu Xu, Stefano Patassini, Nigel M. Hooper, Richard D. Unwin, Garth J. S. Cooper. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia. Metabolites 2021; 11(9) doi: 10.3390/metabo11090569
|
| 76 |
Fang Li, Peng Wang, Zhu Chen, Xiafei Sui, Xinyu Xie, Jinbiao Zhang. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neuroscience Letters 2019; 707 doi: 10.1016/j.neulet.2019.134297
|
| 77 |
Edward Lu, Sumit Sarkar, James Raymick, Merle G. Paule, Qiang Gu. Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Brain Research 2018; 1678 doi: 10.1016/j.brainres.2017.11.014
|
| 78 |
Recent Advances in Parkinson's Disease. Progress in Brain Research 2020; 252 doi: 10.1016/bs.pbr.2020.01.004
|
| 79 |
Alexandra Cosma-Grigorov, Holger Meixner, Anne Mrochen, Stefan Wirtz, Jürgen Winkler, Franz Marxreiter. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates. Frontiers in Neurology 2020; 11 doi: 10.3389/fneur.2020.01041
|
| 80 |
María Elena Gómez-Gómez, Sara C. Zapico. Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions. International Journal of Molecular Sciences 2019; 20(11) doi: 10.3390/ijms20112842
|
| 81 |
Tingting Liu, Haojie Wu, Jianshe Wei. Beyond the Brain: Exploring the multi-organ axes in Parkinson’s disease pathogenesis. Journal of Advanced Research 2026; 80 doi: 10.1016/j.jare.2025.05.034
|
| 82 |
Shobha Kumari, Rajeev Taliyan, Sunil Kumar Dubey. Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson’s Disease. ACS Chemical Neuroscience 2023; 14(4) doi: 10.1021/acschemneuro.2c00730
|
| 83 |
Santosh Kumar Behera, Ardhendu Bhusan Praharaj, Gayathri Chalikonda, Gowru Srivani, Namita Mahapatra. Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies 2020; doi: 10.1007/978-981-15-2017-4_11
|
| 84 |
Claudia Vuotto, Luca Battistini, Carlo Caltagirone, Giovanna Borsellino. Gut Microbiota and Disorders of the Central Nervous System. The Neuroscientist 2020; 26(5-6) doi: 10.1177/1073858420918826
|
| 85 |
Mi Tang, Wei Wang, Jiwen Wang, Yingyan Wang. Alteration of Gut Microbiota by Ketogenic Diet as an Alternative Therapeutic Target for Drug-Resistant Epilepsy. Microorganisms 2025; 13(11) doi: 10.3390/microorganisms13112539
|
| 86 |
Ye Tao, Sean X. Leng, Haiyan Zhang. Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative
Diseases. Current Neuropharmacology 2022; 20(12) doi: 10.2174/1570159X20666220830102628
|
| 87 |
Dmitry I. Trukhan, Anatoly F. Sulimov. Comorbidity of periodontal diseases and Parkinson's disease. Acta medica Eurasica 2025; (2) doi: 10.47026/2413-4864-2025-2-95-104
|
| 88 |
A. S. Baumuratov, P. M. A. Antony, M. Ostaszewski, F. He, L. Salamanca, L. Antunes, J. Weber, L. Longhino, P. Derkinderen, W. J. H. Koopman, N. J. Diederich. Enteric neurons from Parkinson’s disease patients display ex vivo aberrations in mitochondrial structure. Scientific Reports 2016; 6(1) doi: 10.1038/srep33117
|
| 89 |
Dennis P. Jacob, Meenu Viswanath, M. C. Subhash Peter. Hormones in Neuroscience. 2027; doi: 10.1016/B978-0-443-30261-9.00011-5
|
| 90 |
Devina Chetty, Shameemah Abrahams, Riaan van Coller, Jonathan Carr, Colin Kenyon, Soraya Bardien. Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment. European Journal of Neuroscience 2021; 54(2) doi: 10.1111/ejn.15324
|
| 91 |
Wei Li, Xiaoli Wu, Xu Hu, Tao Wang, Shan Liang, Yunfeng Duan, Feng Jin, Bin Qin. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Science China Life Sciences 2017; 60(11) doi: 10.1007/s11427-016-9001-4
|
| 92 |
Fanny M. Elahi, Bruce L. Miller. A clinicopathological approach to the diagnosis of dementia. Nature Reviews Neurology 2017; 13(8) doi: 10.1038/nrneurol.2017.96
|
| 93 |
Deniz Catakli, Ozlem Ozen‐Basoglu, Ebru Busra Tuncgovde, Gonen Ozsarlak‐Sozer. The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective. Basic & Clinical Pharmacology & Toxicology 2026; 139(4) doi: 10.1111/bcpt.70294
|
| 94 |
Claudia Luna-Herrera, Irma A. Martínez-Dávila, Luis O. Soto-Rojas, Yazmin M. Flores-Martinez, Manuel A. Fernandez-Parrilla, Jose Ayala-Davila, Bertha A. León-Chavez, Guadalupe Soto-Rodriguez, Victor M. Blanco-Alvarez, Francisco E. Lopez-Salas, Maria E. Gutierrez-Castillo, Bismark Gatica-Garcia, America Padilla-Viveros, Cecilia Bañuelos, David Reyes-Corona, Armando J. Espadas-Alvarez, Linda Garcés-Ramírez, Oriana Hidalgo-Alegria, Fidel De La Cruz-lópez, Daniel Martinez-Fong, Fabiano Carvalho. Intranigral Administration of β‐Sitosterol‐β‐D‐Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra. Journal of Immunology Research 2020; 2020(1) doi: 10.1155/2020/5907591
|
| 95 |
Carl E. Cerniglia. Handbook of Developmental Neurotoxicology. 2018; doi: 10.1016/B978-0-12-809405-1.00023-7
|
| 96 |
Natasa Kustrimovic, Franca Marino, Marco Cosentino. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease. Current Medicinal Chemistry 2019; 26(20) doi: 10.2174/0929867325666181009161048
|
| 97 |
Sudhir K Dutta, Sandeep Verma, Vardhmaan Jain, Balarama K Surapaneni, Rakesh Vinayek, Laila Phillips, Padmanabhan P Nair. Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. Journal of Neurogastroenterology and Motility 2019; 25(3) doi: 10.5056/jnm19044
|
| 98 |
Mohammad Shabani, Ali Ghoshehy, Amir Mohammad Mottaghi, Zahra Chegini, Azam Kerami, Aref Shariati, Majid Taati Moghadam. The relationship between gut microbiome and human diseases: mechanisms, predisposing factors and potential intervention. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1516010
|
| 99 |
Itsuka Kamimura, Ryou Kaneko, Hidetoshi Morita, Kazutaka Mogi, Takefumi Kikusui. Microbial colonization history modulates anxiety-like and complex social behavior in mice. Neuroscience Research 2021; 168 doi: 10.1016/j.neures.2020.01.001
|
| 100 |
Eneidy Piña Mojica, Nadine Aranis, Joao Victor Ribeiro, Andres Soto-Rodriguez, Felipe Fregni. Evaluation of the impact of microbiome-based therapies on non-motor symptoms in Parkinson's disease: A systematic review and meta-analysis. Gut Microbiology 2026; 2 doi: 10.1016/j.gutmic.2026.100007
|
| 101 |
Xinrong Liu, Shuya Liu, Yong Tang, Zhengjia Pu, Hong Xiao, Jieying Gao, Qi Yin, Yan Jia, Qunhua Bai. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal—Intestinal Inflammation Activited and Intestinal Microbiota—Metabolic Disorders Induced in MPTP Mouse Model of Parkinson’s Disease. Neurochemical Research 2021; 46(6) doi: 10.1007/s11064-021-03293-2
|
| 102 |
Michele Zuppi, Heather L. Hendrickson, Justin M. O’Sullivan, Tommi Vatanen. Phages in the Gut Ecosystem. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.822562
|
| 103 |
Fatemeh Mirab, Mitra Pirhaghi, Daniel E. Otzen, Ali Akbar Saboury. Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(6) doi: 10.1016/j.bbadis.2025.167862
|
| 104 |
Xuelun Zou, Leiyun Wang, Linxiao Xiao, Sai Wang, Le Zhang. Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.975921
|
| 105 |
TINGTING LIU, DINGYOU GUO, JIANSHE WEI. The pathogenesis of Parkinson’s disease and crosstalk with other diseases. BIOCELL 2024; 48(8) doi: 10.32604/biocell.2024.051518
|
| 106 |
Xianyi Lin, Yeru Chen, Piao Zhang, Gang Chen, Youfa Zhou, Xin Yu. The potential mechanism of postoperative cognitive dysfunction in older people. Experimental Gerontology 2020; 130 doi: 10.1016/j.exger.2019.110791
|
| 107 |
Cen Guo, Ya-Jing Huo, Yu Li, Yan Han, Da Zhou. Gut-brain axis: Focus on gut metabolites short-chain fatty acids. World Journal of Clinical Cases 2022; 10(6): 1754-1763 doi: 10.12998/wjcc.v10.i6.1754
|
| 108 |
Junze Geng, Can Liu, Jingyu Xu, Xiaoge Wang, Xinmin Li. Potential relationship between Tourette syndrome and gut microbiome. Jornal de Pediatria 2023; 99(1) doi: 10.1016/j.jped.2022.06.002
|
| 109 |
Cecilia Binda, Loris Riccardo Lopetuso, Gianenrico Rizzatti, Giulia Gibiino, Vincenzo Cennamo, Antonio Gasbarrini. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Digestive and Liver Disease 2018; 50(5) doi: 10.1016/j.dld.2018.02.012
|
| 110 |
Adil Ghafoor, Sahaana Sundar, Tennekoon Karunaratne, Satish S.C. Rao, Amol Sharma. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2023; doi: 10.1016/B978-0-443-13911-6.00028-1
|
| 111 |
Souvik Dubey, Ritwik Ghosh, Mahua Jana Dubey, Samya Sengupta, Shambaditya Das. From allegory to conceptualization, hypothesis and finally evidences: Alzheimer’s dementia, Parkinson's disease "gut–brain axis" and their preclinical phenotype. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2024; 60(1) doi: 10.1186/s41983-024-00863-3
|
| 112 |
Lifan Zhong, Benchi Cai, Qitong Wang, Xi Li, Wendi Xu, Tao Chen. Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson’s Disease Based on the Gut-Brain Axis. Pharmaceuticals 2022; 16(1) doi: 10.3390/ph16010039
|
| 113 |
. 2017; doi: 10.70675/f0642fa8z5c78z4bdfza412z2dea91f47891
|
| 114 |
Claudio Franceschi, Paolo Garagnani, Cristina Morsiani, Maria Conte, Aurelia Santoro, Andrea Grignolio, Daniela Monti, Miriam Capri, Stefano Salvioli. The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates. Frontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00061
|
| 115 |
Yu-Hang Li, Zhong-Xin Jiang, Qian Xu, Ting-Ting Jin, Jin-Fang Huang, Xiao Luan, Chong Li, Xin-Yi Chen, Ka-Hing Wong, Xiao-Li Dong, Xiang-Rong Sun. Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model. Biomedicine & Pharmacotherapy 2024; 174 doi: 10.1016/j.biopha.2024.116518
|
| 116 |
Rafael Franco, Irene Reyes-Resina, Gemma Navarro. Dopamine in Health and Disease: Much More Than a Neurotransmitter. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020109
|
| 117 |
Fabrizio Stocchi, Margherita Torti. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders. International Review of Neurobiology 2017; 134 doi: 10.1016/bs.irn.2017.06.003
|
| 118 |
Sreyashi Chandra, Md. Tanjim Alam, Jhilik Dey, Baby C. Pulikkaparambil Sasidharan, Upasana Ray, Amit K. Srivastava, Sonu Gandhi, Prem P. Tripathi. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Current Topics in Medicinal Chemistry 2020; 20(13) doi: 10.2174/1568026620666200413091101
|
| 119 |
O. Skillington, S. Mills, A. Gupta, E.A. Mayer, C.I.R. Gill, D. Del Rio, K.J. O’Riordan, J.F. Cryan, R.P. Ross, C. Stanton. The contrasting human gut microbiota in early and late life and implications for host health and disease. Nutrition and Healthy Aging 2021; 6(3) doi: 10.3233/NHA-210129
|
| 120 |
Gouxin Huang, Raees Khan, Yilin Zheng, Ping-Chin Lee, Qingnan Li, Imran Khan. Exploring the role of gut microbiota in advancing personalized medicine. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1274925
|
| 121 |
Mengyu Hong, Chi‐Tang Ho, Xin Zhang, Ruilin Zhang, Yanan Liu. Dietary strategies may influence human nerves and emotions by regulating intestinal microbiota: an interesting hypothesis. International Journal of Food Science & Technology 2021; 56(7) doi: 10.1111/ijfs.14986
|
| 122 |
Mauro Giuffrè, Rita Moretti, Giuseppina Campisciano, Alexandre Barcelos Morais da Silveira, Vincenzo Maria Monda, Manola Comar, Stefano Di Bella, Roberta Maria Antonello, Roberto Luzzati, Lory Saveria Crocè. You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS. Journal of Clinical Medicine 2020; 9(11) doi: 10.3390/jcm9113705
|
| 123 |
Rafael Franco, Berta Casanovas, Jordi Camps, Gemma Navarro, Eva Martínez-Pinilla. Antioxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents. Current Issues in Molecular Biology 2021; 43(2) doi: 10.3390/cimb43020047
|
| 124 |
J. Massimo Nunes, Tristan Fillis, Martin J. Page, Chantelle Venter, Ophélie Lancry, Douglas B. Kell, Ursula Windberger, Etheresia Pretorius. Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01551
|
| 125 |
Gitanjali P Panigrahi, Ankita R Rane, Sirisha L Vavilala, Sinjan Choudhary. Deciphering the anti-Parkinson’s activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the α-Synuclein mutants A30P, A53T, E46K, E57K and E35K. The Journal of Biochemistry 2019; 166(6) doi: 10.1093/jb/mvz064
|
| 126 |
Guixuan Wang, Danyang Zou, Xinying Lu, Xin Gu, Yuanyuan Cheng, Tengfei Qi, Yanchun Cheng, Junjun Yu, Meiping Ye, Pingyu Zhou. Gut Microbiota Alternation in Disease Progression of Neurosyphilis. Infection and Drug Resistance 2022; doi: 10.2147/IDR.S389155
|
| 127 |
Rohan Gupta, Smita Kumari, Anusha Senapati, Rashmi K. Ambasta, Pravir Kumar. New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease. Ageing Research Reviews 2023; 90 doi: 10.1016/j.arr.2023.102013
|
| 128 |
Diana D. Álvarez-Luquín, Rubén R. González-Fernández, Eduardo Ichikawa-Escamilla, Martin E. Torres-Velasco, Eduardo Martínez-Martínez, Asiel Arce-Sillas, Víctor H. Juárez-Vaquera, Clara L. Miranda-Narvaez, Marisela Hernández, Laura Adalid-Peralta. Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets. Experimental Neurology 2026; 402 doi: 10.1016/j.expneurol.2026.115764
|
| 129 |
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Felipe Esparza Salazar, Jea-Young Lee, Shalini Jain, Hariom Yadav, Cesario Venturina Borlongan. Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031184
|
| 130 |
David M. James, Elizabeth A. Davidson, Julio Yanes, Baharak Moshiree, Julia E. Dallman. The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.662916
|
| 131 |
Li Xie, Dongmei Chen, Xinghui Zhu, Cisong Cheng. Efficacy and safety of probiotics in Parkinson’s constipation: A systematic review and meta-analysis. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1007654
|
| 132 |
Aarti Singh, Vishakha Vishwakarma, Barkha Singhal. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities—Metabiotics: Probiotics Effector Molecules. Advances in Bioscience and Biotechnology 2018; 9(04) doi: 10.4236/abb.2018.94012
|
| 133 |
N. Gorlé, C. Blaecher, E. Bauwens, C. Vandendriessche, S. Balusu, J. Vandewalle, C. Van Cauwenberghe, E. Van Wonterghem, G. Van Imschoot, C. Liu, R. Ducatelle, C. Libert, F. Haesebrouck, A. Smet, R.E. Vandenbroucke. The choroid plexus epithelium as a novel player in the stomach-brain axis during Helicobacter infection. Brain, Behavior, and Immunity 2018; 69 doi: 10.1016/j.bbi.2017.12.010
|
| 134 |
Guillaume Blivet, Johann Meunier, Francois J. Roman, Jacques Touchon. Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2018; 4(1) doi: 10.1016/j.trci.2017.12.003
|
| 135 |
Federica Del Chierico, Paola Grassini, Andrea Quagliariello, Margherita Torti, Alessandra Russo, Sofia Reddel, Fabrizio Stocchi. The Impact of Intestinal Microbiota on Weight Loss in Parkinson’s Disease Patients: A Pilot Study. Future Microbiology 2020; 15(14) doi: 10.2217/fmb-2019-0336
|
| 136 |
Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness. ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease. Journal of Parkinson's Disease 2021; 11(4) doi: 10.3233/JPD-212731
|
| 137 |
Uzma Noor, Imran Khan, Wen-fei Zheng, Ikram Khan, Shao Li. Microbiota-metabolite dysregulation in depressive and non-depressive Parkinson’s disease: mechanistic and therapeutic implications. Ageing and Neurodegenerative Diseases 2026; 6(2) doi: 10.20517/and.2026.06
|
| 138 |
A. Prysiazhniuk, T. Dovbynchuk, B. Kopiyak, G. Tolstanova. The role of central and peripheral D2R receptors in the mechanism of colonic vascular permeability during experimental colitis in rats. Bulletin of Taras Shevchenko National University of Kyiv. Series: Problems of Physiological Functions Regulation 2017; 22(1) doi: 10.17721/2616_6410.2017.22.39-43
|
| 139 |
Jade E. Kenna, Megan C. Bakeberg, Maddison Y. Abonnel, Frank L. Mastaglia, Ryan S. Anderton, Carlo Colosimo. Impact of Gastrointestinal Symptoms on Health‐Related Quality of Life in an Australian Parkinson’s Disease Cohort. Parkinson's Disease 2022; 2022(1) doi: 10.1155/2022/4053665
|
| 140 |
Dahye Song, Yu-Rim Lee, Seung Min Yu, Jeung Hee An. Crude proline modulates the microbiota–gut–brain axis by attenuating curli-associated α-synuclein accumulation and regulating Wnt/β-catenin signaling in Parkinson's disease. Food & Function 2026; 17(17) doi: 10.1039/D6FO02214F
|
| 141 |
Tianfang Jiang, Gen Li, Jun Xu, Shane Gao, Xu Chen. The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02047
|
| 142 |
Saurav Sarkar, Samapika Routhray, Balamurugan Ramadass, Pradipta Kumar Parida. A Review on the Nasal Microbiome and Various Disease Conditions for Newer Approaches to Treatments. Indian Journal of Otolaryngology and Head & Neck Surgery 2023; 75(S1) doi: 10.1007/s12070-022-03205-y
|
| 143 |
Mohammad Rafi Khezri, Ayda Esmaeili, Morteza Ghasemnejad-Berenji. Role of Bmal1 and Gut Microbiota in Alzheimer’s Disease and Parkinson’s Disease Pathophysiology: The Probable Effect of Melatonin on Their Association. ACS Chemical Neuroscience 2023; 14(21) doi: 10.1021/acschemneuro.3c00418
|
| 144 |
Solène Pradeloux, Katherine Coulombe, Alexandre Jules Kennang Ouamba, Amandine Isenbrandt, Frédéric Calon, Denis Roy, Denis Soulet. Oral Trehalose Intake Modulates the Microbiota–Gut–Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model. Nutrients 2024; 16(19) doi: 10.3390/nu16193309
|
| 145 |
Giuseppe Grosso, Justyna Godos, Fabio Galvano, Edward L. Giovannucci. Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annual Review of Nutrition 2017; 37(1) doi: 10.1146/annurev-nutr-071816-064941
|
| 146 |
Ashwin Rajeev, Indranil Chattopadhyay. Gut Microbiome and Brain Ageing. 2024; doi: 10.1007/978-981-99-8803-7_13
|
| 147 |
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh-Esfehani, Saman Soleimanpour. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clinical Microbiology Reviews 2022; 35(1) doi: 10.1128/CMR.00338-20
|
| 148 |
Eric L. Brown, Heather T. Essigmann, Kristi L. Hoffman, Ashley S. Alexander, Michael Newmark, Zhi-Dong Jiang, Jessika Suescun, Mya C. Schiess, Craig L. Hanis, Herbert L. DuPont. IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes. Journal of Parkinson’s Disease 2023; 13(4) doi: 10.3233/JPD-230066
|
| 149 |
Vagdevi Hangarakatte Ramachandra, Senthilkumar Sivanesan, Anand Koppal, Shanmugam Anandakumar, Matthew D. Howell, Ethirajan Sukumar, Rajagopalan Vijayaraghavan. Embelin and levodopa combination therapy for improved Parkinson’s disease treatment. Translational Neuroscience 2022; 13(1) doi: 10.1515/tnsci-2022-0224
|
| 150 |
Simon Isaiah, Du Toit Loots, Regan Solomons, Martijn van der Kuip, A. Marceline Tutu Van Furth, Shayne Mason. Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00296
|
| 151 |
Rashad Alkasir, Jing Li, Xudong Li, Miao Jin, Baoli Zhu. Human gut microbiota: the links with dementia development. Protein & Cell 2017; 8(2) doi: 10.1007/s13238-016-0338-6
|
| 152 |
Sumel Ashique, Sourav Mohanto, Mohammed Gulzar Ahmed, Neeraj Mishra, Ashish Garg, Dinesh Kumar Chellappan, Timothy Omara, Shabnoor Iqbal, Ivan Kahwa. RETRACTED: Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 2024; 10(13) doi: 10.1016/j.heliyon.2024.e34092
|
| 153 |
Mohammad Pourfridoni, Zohreh Hakemi, Habibeh Mashayekhi‐sardoo, Yousef Baghcheghi. Molecular Pathogenesis of Memory Impairment in Parkinson's Disease: An Exploration of Underlying Mechanisms. Health Science Reports 2026; 9(4) doi: 10.1002/hsr2.72024
|
| 154 |
Marco Sancandi, Carmen De Caro, Neringa Cypaite, Nadia Marascio, Carmen Avagliano, Carmela De Marco, Emilio Russo, Andrew Constanti, Audrey Mercer. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model. Frontiers in Aging Neuroscience 2023; 14 doi: 10.3389/fnagi.2022.986127
|
| 155 |
Zhe Li, Hongfeng Liang, Yingyu Hu, Lin Lu, Chunye Zheng, Yuzhen Fan, Bin Wu, Tao Zou, Xiaodong Luo, Xinchun Zhang, Yan Zeng, Ziyan Liu, Zhicheng Zhou, Zhenyu Yue, Yi Ren, Zhuo Li, Qiaozhen Su, Pingyi Xu. Gut bacterial profiles in Parkinson's disease: A systematic review. CNS Neuroscience & Therapeutics 2023; 29(1) doi: 10.1111/cns.13990
|
| 156 |
Kaixiong Liu, Qifu Guo, Ying Ding, Li Luo, Jianchai Huang, Qijie Zhang. Alterations in nasal microbiota of patients with amyotrophic lateral sclerosis. Chinese Medical Journal 2024; 137(2) doi: 10.1097/CM9.0000000000002701
|
| 157 |
Deniz Erturk‐Hasdemir, Dennis L. Kasper. Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor. Annals of the New York Academy of Sciences 2018; 1417(1) doi: 10.1111/nyas.13660
|
| 158 |
Zimo Zang, Fang Yang, Liang Qu, Minghui Ge, Liang Tong, Lihui Xue, Xiuye Sun, Ying Hai. Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson’s disease treatment. Frontiers in Aging Neuroscience 2025; 17 doi: 10.3389/fnagi.2025.1640389
|
| 159 |
Dorota Koníčková, Kateřina Menšíková, Lucie Plíhalová, Petr Kaňovský. Effects of active compounds and their metabolites associated with coffee consumption on neurodegenerative disease. Nutrition Research Reviews 2025; 38(2) doi: 10.1017/S0954422424000349
|
| 160 |
Changlin Lian, Nan Ding, Zhifeng Xu, Jingyi Liao, Lixin Pan, Wenjie Lai, Lu Yang, Shenglin Wu, Guanghua Zhao, Dezhi Zheng, Xiaofang Ou, Haoli Zheng, Xiaogang Zhang, Yukai Wang. Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models. Brain Research 2026; 1889 doi: 10.1016/j.brainres.2026.150449
|
| 161 |
Yun Shi, Chen-Meng Qiao, Yu Zhou, Ji Wu, Chun Cui, Hui Hong, Xue-Bing Jia, Shu-Bing Huang, Li Yao, Wei-Jiang Zhao, Yan-Qin Shen. Protective effects of prucalopride in MPTP-induced Parkinson’s disease mice: Neurochemistry, motor function and gut barrier. Biochemical and Biophysical Research Communications 2021; 556 doi: 10.1016/j.bbrc.2021.03.109
|
| 162 |
Yingjie Shen, Hao Liu, Xiangyi Meng, Aili Gao, Yansong Liu, Wei Ma, Hongsheng Liang, Fulan Hu. The causal effects between gut microbiota and hemorrhagic stroke: a bidirectional two-sample Mendelian randomization study. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1290909
|
| 163 |
Adonis Sfera, Kelsey Bullock, Amy Price, Luzmin Inderias, Carolina Osorio. Ferrosenescence: The iron age of neurodegeneration?. Mechanisms of Ageing and Development 2018; 174 doi: 10.1016/j.mad.2017.11.012
|
| 164 |
Ai Huey Tan, Jia Wei Hor, Chun Wie Chong, Shen‐Yang Lim. Probiotics for Parkinson's disease: Current evidence and future directions. JGH Open 2021; 5(4) doi: 10.1002/jgh3.12450
|
| 165 |
Lauren Talman, Delaram Safarpour. An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes. Seminars in Neurology 2023; 43(04) doi: 10.1055/s-0043-1771461
|
| 166 |
Sophia Alexandre de Queiroz Cavalcanti, Leonardo Augusto de Almeida, Juciano Gasparotto. Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development. Journal of Neuroimmunology 2023; 382 doi: 10.1016/j.jneuroim.2023.578171
|
| 167 |
Dilyar Tuigunov, Yuriy Sinyavskiy, Talgat Nurgozhin, Zhibek Zholdassova, Galiya Smagul, Yerzhan Omarov, Oksana Dolmatova, Ainur Yeshmanova, Indira Omarova. Precision Nutrition and Gut–Brain Axis Modulation in the Prevention of Neurodegenerative Diseases. Nutrients 2025; 17(19) doi: 10.3390/nu17193068
|
| 168 |
Shehnaz Wasim, Vishal Kukkar, Vanessa M Awad, Sirisha Sakhamuru, Bilal Haider Malik. Neuroprotective and Neurodegenerative Aspects of Coffee and Its Active Ingredients in View of Scientific Literature. Cureus 2020; doi: 10.7759/cureus.9578
|
| 169 |
Xin Zhao, Juqing Ai, Haoping Mao, Xiumei Gao. Effects of Eclipta prostrata on gut microbiota of SAMP6 mice with osteoporosis. Journal of Medical Microbiology 2019; 68(3) doi: 10.1099/jmm.0.000936
|
| 170 |
Jian-Fu Liao, Yun-Fang Cheng, Shu-Ting You, Wen-Chun Kuo, Chi-Wei Huang, Jen-Jie Chiou, Chih-Chieh Hsu, Hsiu-Mei Hsieh-Li, Sabrina Wang, Ying-Chieh Tsai. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease. Brain, Behavior, and Immunity 2020; 90 doi: 10.1016/j.bbi.2020.07.036
|
| 171 |
Esmail Alipour Nosrani, Omid Reza Tamtaji, Zahra Alibolandi, Parichehr Sarkar, Mohsen Ghazanfari, Abolfazl Azami Tameh, Mohsen Taghizadeh, Zarrin Banikazemi, Razie Hadavi, Mojtaba Naderi Taheri. Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. Journal of Immunoassay and Immunochemistry 2021; 42(2) doi: 10.1080/15321819.2020.1833917
|
| 172 |
Yogesh Singh, Christoph Trautwein, Joan Romani, Madhuri S. Salker, Peter H. Neckel, Isabel Fraccaroli, Mahkameh Abeditashi, Nils Woerner, Jakob Admard, Achal Dhariwal, Morten K. D. Dueholm, Karl-Herbert Schäfer, Florian Lang, Daniel E. Otzen, Hilal A. Lashuel, Olaf Riess, Nicolas Casadei. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease. Molecular Neurodegeneration 2023; 18(1) doi: 10.1186/s13024-023-00628-1
|
| 173 |
Liqin Liang, Shijia Li, Yuanyuan Huang, Jing Zhou, Dongsheng Xiong, Shaochuan Li, Hehua Li, Baoyuan Zhu, Xiaobo Li, Yuping Ning, Xiaohui Hou, Fengchun Wu, Kai Wu. Relationships among the gut microbiome, brain networks, and symptom severity in schizophrenia patients: A mediation analysis. NeuroImage: Clinical 2024; 41 doi: 10.1016/j.nicl.2024.103567
|
| 174 |
Lihong Li, Jun Lu, Yingying Sun, Xiaoqing Jin. Acupuncture protects from 6-OHDA-induced neuronal damage by balancing the ratio of DMT1/Fpn1. Saudi Journal of Biological Sciences 2019; 26(8) doi: 10.1016/j.sjbs.2019.07.003
|
| 175 |
Anshul Sinha, Corinne F. Maurice. Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System. Mediators of Inflammation 2019; 2019 doi: 10.1155/2019/3730519
|
| 176 |
Disha Tandon, Mohammed Monzoorul Haque, Saravanan R., Shafiq Shaikh, Sriram P., Ashok Kumar Dubey, Sharmila S. Mande, Pankaj Kumar Arora. A snapshot of gut microbiota of an adult urban population from Western region of India. PLOS ONE 2018; 13(4) doi: 10.1371/journal.pone.0195643
|
| 177 |
Nour Abou Izzeddine, Kawsar Ahmad, Christine Bacha, Maria Jabbour, Mouin Najjar, Sethrida Salhab, Hilda E. Ghadieh, Amjad Kanaan, Sami Azar, Ziad Abi Khattar, Frederic Harb. The microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease. IBRO Neuroscience Reports 2025; 19 doi: 10.1016/j.ibneur.2025.05.014
|
| 178 |
Nan Zhang, Fangyuan Zhao, Tingting Miao, Nan Wang, Jiahui Wu, Shuting Tan, Xiang Wang, Xier Lihou, Yan Li, Yang Li, Feng Ou, Maochun Xiao, Aji Li, Rongting Min, Shiyao Su, Xueyong Wang. Type 3 resistant starch from Canna edulis improves Parkinson’s symptoms, including behavioral function and nerve damage, in Parkinson’s model rats by regulating the gut–brain axis. The Journal of Nutritional Biochemistry 2026; 151 doi: 10.1016/j.jnutbio.2025.110191
|
| 179 |
Elizabeth Lipski. Integrative and Functional Medical Nutrition Therapy. 2020; doi: 10.1007/978-3-030-30730-1_23
|
| 180 |
Artem Minalyan, Lilit Gabrielyan, Claudio Pietra, Yvette Taché, Lixin Wang. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats. Frontiers in Integrative Neuroscience 2019; 13 doi: 10.3389/fnint.2019.00013
|
| 181 |
Geir Bjørklund, Lyudmila Pivina, Maryam Dadar, Nagwa A. Meguid, Yuliya Semenova, Mona Anwar, Salvatore Chirumbolo. Gastrointestinal alterations in autism spectrum disorder: What do we know?. Neuroscience & Biobehavioral Reviews 2020; 118 doi: 10.1016/j.neubiorev.2020.06.033
|
| 182 |
Zhenxiong Zhao, Mengdie Dong, Zhen Mu, Zhencang Zheng, Zhengwei Zhang. Gut-brain axis dysregulation in Parkinson's disease: Mechanisms linking microbiota to neuroinflammation and α-synuclein pathology. Journal of Pharmaceutical Analysis 2026; 16(8) doi: 10.1016/j.jpha.2025.101521
|
| 183 |
Nicolas A Karakatsanis, Mohammad H Nehmeh, Maurizio Conti, Girish Bal, Antonio J González, Sadek A Nehmeh. Physical performance of adaptive axial FOV PET scanners with a sparse detector block rings or a checkerboard configuration. Physics in Medicine & Biology 2022; 67(10) doi: 10.1088/1361-6560/ac6aa1
|
| 184 |
Ali Mirza, Yang Mao-Draayer. The gut microbiome and microbial translocation in multiple sclerosis. Clinical Immunology 2017; 183 doi: 10.1016/j.clim.2017.03.001
|
| 185 |
Zijiao Yang, Chengfu Song, Chong Lu. Investigation of the causal relationship between cholelithiasis and Parkinson's disease: A bidirectional Mendelian randomization study. Health Science Reports 2024; 7(10) doi: 10.1002/hsr2.70126
|
| 186 |
Fatima Khan, Shariq Ahmed, Uzma Tayyaba. Human Microbiome and their Implications for Oncological Diagnosis and Treatment. 2026; doi: 10.1016/B978-0-443-40551-8.00005-6
|
| 187 |
Tong Zhang, Rui Yang, Juhua Pan, Shijing Huang. Parkinson’s Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022). Neuropsychiatric Disease and Treatment 2023; doi: 10.2147/NDT.S403002
|
| 188 |
Sarah Vascellari, Vanessa Palmas, Marta Melis, Silvia Pisanu, Roberto Cusano, Paolo Uva, Daniela Perra, Veronica Madau, Marianna Sarchioto, Valentina Oppo, Nicola Simola, Micaela Morelli, Maria Laura Santoru, Luigi Atzori, Maurizio Melis, Giovanni Cossu, Aldo Manzin, Vanni Bucci. Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease. mSystems 2020; 5(5) doi: 10.1128/mSystems.00561-20
|
| 189 |
Ai Huey Tan, Chun Wie Chong, Shen‐Yang Lim, Ivan Kok Seng Yap, Cindy Shuan Ju Teh, Mun Fai Loke, Sze‐Looi Song, Jiun Yan Tan, Ban Hong Ang, Yong Qi Tan, Mee Teck Kho, Jeff Bowman, Sanjiv Mahadeva, Hoi Sen Yong, Anthony E. Lang. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics. Annals of Neurology 2021; 89(3) doi: 10.1002/ana.25982
|
| 190 |
Ünkan Urganci, Fatma Isik. Dietary Interventions in Neurodegenerative Diseases. Analecta Technica Szegedinensia 2025; 19(3-4) doi: 10.14232/analecta.2025.3-4.48-73
|
| 191 |
K Ray Chaudhuri, Nataliya Titova. Societal Burden and Persisting Unmet Needs of Parkinson’s Disease. European Neurological Review 2019; 14(1) doi: 10.17925/ENR.2019.14.1.28
|
| 192 |
Leila Kafshdooz, Reza Safaralizadeh. Gut microbiota–nanoparticle interactions in Parkinson’s disease: mechanistic insights and therapeutic perspective. Artificial Cells, Nanomedicine, and Biotechnology 2026; 54(1) doi: 10.1080/21691401.2026.2694921
|
| 193 |
Ali Rezaie, Mark Pimentel, Satish S. Rao. How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach. Current Gastroenterology Reports 2016; 18(2) doi: 10.1007/s11894-015-0482-9
|
| 194 |
Irene Righetto, Matteo Gasparotto, Laura Casalino, Marcella Vacca, Francesco Filippini. Exogenous Players in Mitochondria-Related CNS Disorders: Viral Pathogens and Unbalanced Microbiota in the Gut-Brain Axis. Biomolecules 2023; 13(1) doi: 10.3390/biom13010169
|
| 195 |
Qinghui He, Congcong Si, Zhenjiao Sun, Yuhui Chen, Xin Zhang. The Intervention of Prebiotics on Depression via the Gut–Brain Axis. Molecules 2022; 27(12) doi: 10.3390/molecules27123671
|
| 196 |
Sanne van Erp, Ece Ercan, Perla Breedveld, Lianne Brakenhoff, Eidrees Ghariq, Sophie Schmid, Matthias van Osch, Mark van Buchem, Bart Emmer, Jeroen van der Grond, Ron Wolterbeek, Daniel Hommes, Herma Fidder, Nic van der Wee, Tom Huizinga, Désirée van der Heijde, Huub Middelkoop, Itamar Ronen, Andrea van der Meulen-de Jong. Cerebral magnetic resonance imaging in quiescent Crohn’s disease patients with fatigue. World Journal of Gastroenterology 2017; 23(6): 1018-1029 doi: 10.3748/wjg.v23.i6.1018
|
| 197 |
Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 2021; 12(1): 21-31 doi: 10.4292/wjgpt.v12.i1.21
|
| 198 |
Mădălina Preda, Mircea Ioan Popa, Mara Mădălina Mihai, Teodora Cristiana Oţelea, Alina Maria Holban. Caffeinated and Cocoa Based Beverages. 2019; doi: 10.1016/B978-0-12-815864-7.00012-X
|
| 199 |
Tianyu Meng, Yufei Zhang, Shoupeng Fu, Shaohua Ma.
Gpr35 Expression Mitigates Neuroinflammation and Enriches Gut
Lactobacillus
to Relieve Parkinson’s Disease
. Research 2025; 8 doi: 10.34133/research.0846
|
| 200 |
Mohaddeseh Ghorbani Shiraz, Janni Nielsen, Jeremias Widmann, Ka Hang Karen Chung, Thomas Paul Davis, Casper Rasmussen, Carsten Scavenius, Jan J. Enghild, Camille Martin-Gallausiaux, Yogesh Singh, Ibrahim Javed, Daniel E. Otzen. Young rat microbiota extracts strongly inhibit fibrillation of α-synuclein and protect neuroblastoma cells and zebrafish against α-synuclein toxicity. Molecules and Cells 2025; 48(1) doi: 10.1016/j.mocell.2024.100161
|
| 201 |
Susan Westfall, Nikita Lomis, Imen Kahouli, Si Yuan Dia, Surya Pratap Singh, Satya Prakash. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cellular and Molecular Life Sciences 2017; 74(20) doi: 10.1007/s00018-017-2550-9
|
| 202 |
Iman Beheshti. Exploring Risk and Protective Factors in Parkinson’s Disease. Cells 2025; 14(10) doi: 10.3390/cells14100710
|
| 203 |
Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease. Current Neuropharmacology 2020; 19(2) doi: 10.2174/1570159X18666200606233050
|
| 204 |
Qiang Fu, Siyi Zhou, Mengting Yu, Yang Lu, Genhe He, Xiaoliu Huang, Yushan Huang. Portulaca oleracea Polysaccharides Modulate Intestinal Microflora in Aged Rats in vitro. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.841397
|
| 205 |
|
| 206 |
Maria Belen Justich, Olga L. Rojas, Alfonso Fasano. The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease. Seminars in Neurology 2023; 43(04) doi: 10.1055/s-0043-1771468
|
| 207 |
Paolo Riccio, Rocco Rossano. Undigested Food and Gut Microbiota May Cooperate in the Pathogenesis of Neuroinflammatory Diseases: A Matter of Barriers and a Proposal on the Origin of Organ Specificity. Nutrients 2019; 11(11) doi: 10.3390/nu11112714
|
| 208 |
Stroe Alina Zorina. Cancer in Parkinson’s Disease, a Review of Literature. ARS Medica Tomitana 2021; 27(4) doi: 10.2478/arsm-2021-0034
|
| 209 |
Xiuli Lin, Yingying Liu, Lili Ma, Xiaomeng Ma, Liping Shen, Xueying Ma, Zhaoyu Chen, Hao Chen, Donghong Li, Zhumin Su, Xiaohong Chen. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02995-z
|
| 210 |
Gözde EMİNOĞLU. Beslenmenin Psikolojik Durum Üzerinde Olumlu ya da Olumsuz Etkisinin Araştırılması: Üniversite Öğrencilerinde Bir Anket Çalışması. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020; doi: 10.33631/duzcesbed.762252
|
| 211 |
|
| 212 |
Kirsi Murtomäki, Juho Joutsa, Tuomas Mertsalmi, Elina Jaakkola, Elina Mäkinen, Reeta Levo, Mikael Eklund, Simo Nuuttila, Eero Pekkonen, Tommi Noponen, Toni Ihalainen, Valtteri Kaasinen, Filip Scheperjans. Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease. Brain and Behavior 2023; 13(7) doi: 10.1002/brb3.3097
|
| 213 |
Joy Leng, Chris Proudman, Alistair Darby, Frances Blow, Neil Townsend, Andrew Miller, Jonathan Swann. Exploration of the Fecal Microbiota and Biomarker Discovery in Equine Grass Sickness. Journal of Proteome Research 2018; 17(3) doi: 10.1021/acs.jproteome.7b00784
|
| 214 |
Thomas Foki, Birgit Riemer, Bianca Brim, Walter Struhal. Non-Motor Parkinson's Disease. 2022; doi: 10.1017/9781009039291.013
|
| 215 |
Laura de Magistris, Dario Siniscalco, Carmela Bravaccio, Carmelina Loguercio. Human Nutrition from the Gastroenterologist’s Perspective. 2016; doi: 10.1007/978-3-319-30361-1_4
|
| 216 |
Yumna El-Hakim, Kathiresh Kumar Mani, Kaylin A. Pickle, Zara Akbari, Nadia Samiya, Chloe Pham, Gianna Salas, Rachel Pilla, Farida Sohrabji. Peripheral, but not central, IGF-1 treatment attenuates stroke-induced cognitive impairment in middle-aged female Sprague Dawley rats: The gut as a therapeutic target. Brain, Behavior, and Immunity 2024; 122 doi: 10.1016/j.bbi.2024.08.008
|
| 217 |
Lady Johanna Forero-Rodríguez, Jonathan Josephs-Spaulding, Stefano Flor, Andrés Pinzón, Christoph Kaleta. Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach. Antioxidants 2021; 11(1) doi: 10.3390/antiox11010071
|
| 218 |
Yu-Tang Tung, Tu-Hsueh Yeh, Shu-Ping Tsao, Chun-Hsu Pan, Wen-Chao Chen, Wei-Ting Shih, Chih-Hsuan Lou, Hui-Yu Huang. Therapeutic Effects of Low-Intensity Treadmill Exercise on Motor and Non-Motor Symptoms in a 6-Hydroxydopamine (OHDA) Rat Model of Parkinson’s Disease via Gut–Brain Axis Modulation. Molecular Neurobiology 2026; 63(1) doi: 10.1007/s12035-025-05444-w
|
| 219 |
Karol Kowalski, Agata Mulak. Brain-Gut-Microbiota Axis in Alzheimer’s Disease. Journal of Neurogastroenterology and Motility 2019; 25(1) doi: 10.5056/jnm18087
|
| 220 |
Melania Melis, Antje Haehner, Mariano Mastinu, Thomas Hummel, Iole Tomassini Barbarossa. Molecular and Genetic Factors Involved in Olfactory and Gustatory Deficits and Associations with Microbiota in Parkinson’s Disease. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084286
|
| 221 |
Petros Georgopoulos, Konstantinos-Vaios Mytilekas, Apostolos Apostolidis. Neuro-Urology. 2018; doi: 10.1007/978-3-319-90997-4_5
|
| 222 |
Xin Liu, Zhong-Rui Du, Xiong Wang, Kar-Him Luk, Cheuk-Hin Chan, Xu Cao, Qing Zhao, Fang Zhao, Wing-Tak Wong, Ka-Hing Wong, Xiao-Li Dong. Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson’s Disease Mice Model. Frontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.649627
|
| 223 |
Xiao-Chong Li, Bang-Sheng Wu, Yi Jiang, Jie Li, Ze-Fen Wang, Chao Ma, Yi-Rong Li, Jie Yao, Xiao-Qing Jin, Zhi-Qiang Li. Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma. Drug Design, Development and Therapy 2021; doi: 10.2147/DDDT.S298261
|
| 224 |
Sidra Khan, Aparna Gupta, Aman Agarwal, Mohammad Ajaz Alam, Sai Gautham Kanagala, Rohit Jain. Beyond the brain: The colorectal impact of Parkinson's disease. Journal of Parkinson’s Disease 2025; 15(8) doi: 10.1177/1877718X251380261
|
| 225 |
Xinfu Zou, Guoqiang Zou, Xinyan Zou, Kangfeng Wang, Zetao Chen. Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment. PeerJ 2024; 12 doi: 10.7717/peerj.17061
|
| 226 |
Monalisa Rout, Shakti Ketan Prusty, Durga Madhab Kar. Probiotic: A Gut Microbiota-Based Therapeutic Approaches for the Treatment of Parkinson’s Disease. Current Reviews in Clinical and Experimental Pharmacology 2025; 20(4) doi: 10.2174/0127724328332572241219102122
|
| 227 |
Teodora Surdea Blaga, Dan L. Dumitrascu, Andrei V. Pop, Simona Grad. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021; doi: 10.1016/B978-0-12-821927-0.00008-5
|
| 228 |
George B. Stefano, Richard M. Kream. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders. Cellular and Molecular Neurobiology 2022; 42(1) doi: 10.1007/s10571-021-01117-z
|
| 229 |
Xinru Huang, Hao Wu, Xiao Wu, Weiwei Su, Peibo Li. Naringenin/naringin therapeutic effects and the role of intestinal microflora in them. Pharmacological Research 2025; 219 doi: 10.1016/j.phrs.2025.107871
|
| 230 |
Diego Cabezudo, Veerle Baekelandt, Evy Lobbestael. Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00376
|
| 231 |
Raghad Tabaza, Richard E. Hartman. Impact of Gut–Brain Axis and Probiotics on Alzheimer’s Disease. Neurology International 2025; 17(10) doi: 10.3390/neurolint17100153
|
| 232 |
N. G. Zhukova, Z. F. Sayfitdinkhuzhaev, G. M. Israilova, O. Ya. Bustonov, N. A. Nasriddinova, O. V. Gaponova, I. A. Zhukova, A. Ya. Masenko. The Brain–Gut–Microbiome Axis in Patients with Parkinson’s Disease. Neuroscience and Behavioral Physiology 2026; 56(3) doi: 10.1007/s11055-026-01998-x
|
| 233 |
Roberta J. Ward, David T. Dexter, Robert R. Crichton. Iron, Neuroinflammation and Neurodegeneration. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137267
|
| 234 |
Oksana Zatorska. Impact of gut microbiota on the central nervous system relevance in neurodegenerative and psychiatric diseases. Current Problems of Psychiatry 2024; 25 doi: 10.12923/2353-8627/2024-0022
|
| 235 |
Yasir Bashir, Asad U. Khan. The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.1030694
|
| 236 |
Zhengjia Pu, Shuya Liu, Zeming Guo, Xuemei Zhang, Jie Yan, Yong Tang, Hong Xiao, Jieying Gao, Yingli Li, Qunhua Bai. Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model. Neuroscience 2023; 524 doi: 10.1016/j.neuroscience.2023.05.014
|
| 237 |
Sara Ekmark‐Lewén, Veronica Lindström, Astrid Gumucio, Elisabeth Ihse, Anish Behere, Philipp J. Kahle, Eva Nordström, Maria Eriksson, Anna Erlandsson, Joakim Bergström, Martin Ingelsson. Early fine motor impairment and behavioral dysfunction in (Thy‐1)‐h[A30P] alpha‐synuclein mice. Brain and Behavior 2018; 8(3) doi: 10.1002/brb3.915
|
| 238 |
Navid Leelani, Petar Bajic, Neel Parekh, Sarah C. Vij, Scott D. Lundy. The emerging role of the gut-testis axis in male reproductive health and infertility. F&S Reviews 2023; 4(2) doi: 10.1016/j.xfnr.2023.01.001
|
| 239 |
Li Liu, Yan Zhao, Weixing Yang, Yuqin Fan, Lixiang Han, Jun Sheng, Yang Tian, Xiaoyu Gao. Rotenone Induces Parkinsonism with Constipation Symptoms in Mice by Disrupting the Gut Microecosystem, Inhibiting the PI3K-AKT Signaling Pathway and Gastrointestinal Motility. International Journal of Molecular Sciences 2025; 26(5) doi: 10.3390/ijms26052079
|
| 240 |
Minh Tran, Hoe Won Jeong, Minjoon An, Chaeyeon Been, Ariunzaya Jamsranjav, Seung Min Kwak, Luke P. Lee, Hansang Cho. A 3D gut-brain-vascular platform for bidirectional crosstalk in gut-neuropathogenesis. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-69318-y
|
| 241 |
Stepan Avagyan, Armen Muradyan, Marina Makletsova, V Poleshchuk, Arto Zilfyan. The role of aliphatic polyamines and α-synuclein in the formation of peripheral mechanisms involved in the Parkinson’s disease induction. THE NEW ARMENIAN MEDICAL JOURNAL 2025; 19(3) doi: 10.56936/18290825-3.19v.2025-4
|
| 242 |
Saba Kurtom, Vrishketan Sethi, Vikas Dudeja. Textbook of Pancreatic Cancer. 2021; doi: 10.1007/978-3-030-53786-9_19
|
| 243 |
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi, Chaiyavat Chaiyasut. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 2022; 10(8) doi: 10.3390/microorganisms10081544
|
| 244 |
Jingyi He, Guofu Zhu, Guoqing Wang, Feng Zhang. Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/6137521
|
| 245 |
|
| 246 |
Mouhammad Sharifa, Tanmay Ghosh, Omar A Daher , Pramod Bhusal, Yasoob A Alaameri, Javeria Naz, Chukwuyem Ekhator , Sophia B Bellegarde, Pakeezah Bisharat, Viralkumar Vaghani, Azlaan Hussain. Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights. Cureus 2023; doi: 10.7759/cureus.47058
|
| 247 |
Nicola Principi, Susanna Esposito. Gut microbiota and central nervous system development. Journal of Infection 2016; 73(6) doi: 10.1016/j.jinf.2016.09.010
|
| 248 |
Agnieszka Gadecka, Anna Bielak-Zmijewska. Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome. Nutrients 2019; 11(6) doi: 10.3390/nu11061251
|
| 249 |
Ai Huey Tan, Shen Yang Lim, Anthony E. Lang. The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic. Nature Reviews Neurology 2022; 18(8) doi: 10.1038/s41582-022-00681-2
|
| 250 |
Qin Zhang, Kangyu Jin, Bing Chen, Ripeng Liu, Shangping Cheng, Yuyan Zhang, Jing Lu. Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.884579
|
| 251 |
Jing-Jing Shi, Cheng-Yuan Mao, Ya-Zhou Guo, Yu Fan, Xiao-Yan Hao, Shuang-Jie Li, Jie Tian, Zheng-Wei Hu, Meng-Jie Li, Jia-Di Li, Dong-Rui Ma, Meng-Nan Guo, Chun-Yan Zuo, Yuan-Yuan Liang, Yu-Ming Xu, Jian Yang, Chang-He Shi. Joint analysis of proteome, transcriptome, and multi-trait analysis to identify novel Parkinson’s disease risk genes. Aging 2024; 16(2) doi: 10.18632/aging.205444
|
| 252 |
Scott A. Myers, Leila Gobejishvili, Sujata Saraswat Ohri, C. Garrett Wilson, Kariena R. Andres, Amberly S. Riegler, Hridgandh Donde, Swati Joshi-Barve, Shirish Barve, Scott R. Whittemore. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiology of Disease 2019; 124 doi: 10.1016/j.nbd.2018.12.008
|
| 253 |
Martha Teresa Acosta-Mejia, Nelson Villalobos. Neurophysiology of Brain Networks Underlies Symptoms of Parkinson’s Disease: A Basis for Diagnosis and Management. Diagnostics 2023; 13(14) doi: 10.3390/diagnostics13142394
|
| 254 |
Robert P. Smith, Cole Easson, Sarah M. Lyle, Ritishka Kapoor, Chase P. Donnelly, Eileen J. Davidson, Esha Parikh, Jose V. Lopez, Jaime L. Tartar, Palok Aich. Gut microbiome diversity is associated with sleep physiology in humans. PLOS ONE 2019; 14(10) doi: 10.1371/journal.pone.0222394
|
| 255 |
Caroline Haikal, Qian-Qian Chen, Jia-Yi Li. Microbiome changes: an indicator of Parkinson’s disease?. Translational Neurodegeneration 2019; 8(1) doi: 10.1186/s40035-019-0175-7
|
| 256 |
Beyza Tağraf, Özden Erkan Oğul, Deniz Yerlikaya, Lütfü Hanoğlu. A personalized plant-rich, time-restricted nutritional intervention for motor and non-motor symptoms in Parkinson's disease: A randomized controlled trial. Journal of Parkinson’s Disease 2026; 16(2) doi: 10.1177/1877718X261422067
|
| 257 |
. 2022; doi: 10.70675/f288cc90zc0f8z4d09z96b8za6c2e6ec3635
|
| 258 |
The Microbiome. Progress in Molecular Biology and Translational Science 2020; 176 doi: 10.1016/bs.pmbts.2020.08.010
|
| 259 |
Xueling Zhu, Bo Li, Pengcheng Lou, Tingting Dai, Yang Chen, Aoxiang Zhuge, Yin Yuan, Lanjuan Li. The Relationship Between the Gut Microbiome and Neurodegenerative Diseases. Neuroscience Bulletin 2021; 37(10) doi: 10.1007/s12264-021-00730-8
|
| 260 |
Grace Hey, Navya Nair, Emily Klann, Anjela Gurrala, Delaram Safarpour, Volker Mai, Adolfo Ramirez-Zamora, Vinata Vedam-Mai. Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1151850
|
| 261 |
Sara Licaj, Alexander Ploner, Agnieszka Szwajda, Sara Hägg, Fang Fang, Jonas F Ludvigsson, Karin Wirdefeldt.
Helicobacter pylori
infection, peptic ulcer, gastritis and risk of Parkinson's disease: A nationwide matched cohort study
. Journal of Parkinson’s Disease 2026; 16(6) doi: 10.1177/1877718X261466875
|
| 262 |
Xiaoqing Li, Xin Feng, Zhongxiang Jiang, Zheng Jiang. Association of small intestinal bacterial overgrowth with Parkinson’s disease: a systematic review and meta-analysis. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00420-w
|
| 263 |
Chen Song, Fangyuan Duan, Ting Ju, Yue Qin, Deyong Zeng, Shan Shan, Yudong Shi, Yingchun Zhang, Weihong Lu. Eleutheroside E supplementation prevents radiation-induced cognitive impairment and activates PKA signaling via gut microbiota. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-03602-7
|
| 264 |
Joyce K. Y. Tse. Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders. ACS Chemical Neuroscience 2017; 8(7) doi: 10.1021/acschemneuro.7b00176
|
| 265 |
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, Jaroslaw Bilinski, Elisabetta Caselli, Elena M. Comelli, Markus Egert, Cristina Giaroni, Tomasz M. Karpinski, Igor Loniewski, Agata Mulak, Julie Reygner, Paulina Samczuk, Matteo Serino, Mariusz Sikora, Annalisa Terranegra, Marcin Ufnal, Romain Villeger, Chantal Pichon, Peter Konturek, Marvin Edeas. Microbiota medicine: towards clinical revolution. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03296-9
|
| 266 |
E. Fernández-Espejo. Microorganismos relacionados con un mayor riesgo de presentar la enfermedad de Parkinson. Neurología 2023; 38(7) doi: 10.1016/j.nrl.2020.08.020
|
| 267 |
Hao Cheng, Dandan Zhang, Jing Wu, Juan Liu, Yaochuan Zhou, Yuzhu Tan, Wuwen Feng, Cheng Peng. Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review. Phytomedicine 2023; 119 doi: 10.1016/j.phymed.2023.154979
|
| 268 |
Bilal El-Mansoury, Kamal Smimih, Abdelaati El Khiat, Hanane El Fatimi, Abdelmohcine Aimrane, Soraia El Baz, Abdessamad Elmourid, Fatima Ez-Zahraa Saad, Hafida El Ghachi, Manal Khanouchi, Arumugam Radhakrishnan Jayakumar, Abdeljalil Zoubadi. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. Advances in Medical Diagnosis, Treatment, and Care 2023; doi: 10.4018/978-1-6684-5156-4.ch017
|
| 269 |
María Paz Valdivieso Castro, Julio Cesar Ojeda Sánchez, Jorge Eduardo Ochoa Aucay. The role of the intestine as a target with a therapeutic role in people with neurodegenerative diseases. Salud, Ciencia y Tecnología 2023; 3 doi: 10.56294/saludcyt2023310
|
| 270 |
Loredana Matiș, Lucia Georgeta Daina, Lavinia Maris, Timea Claudia Ghitea, Daniela Florina Trifan, Ioana Moga, Radu Fodor. Variety of Serotonin Levels in Pediatric Gastrointestinal Disorders. Diagnostics 2023; 13(24) doi: 10.3390/diagnostics13243675
|
| 271 |
Alba Montalbán-Rodríguez, Raquel Abalo, Laura López-Gómez. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease. International Journal of Molecular Sciences 2024; 25(2) doi: 10.3390/ijms25021294
|
| 272 |
Shaosong Xi, Yunguang Wang, Chenghao Wu, Weihua Peng, Ying Zhu, Wei Hu. Intestinal Epithelial Cell Exosome Launches IL-1β-Mediated Neuron Injury in Sepsis-Associated Encephalopathy. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.783049
|
| 273 |
Corneliu Toader, Calin Petru Tataru, Octavian Munteanu, Razvan-Adrian Covache-Busuioc, Matei Serban, Alexandru Vlad Ciurea, Mihaly Enyedi. Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders. International Journal of Molecular Sciences 2024; 25(24) doi: 10.3390/ijms252413614
|
| 274 |
Xuxiang Zhang, Beisha Tang, Jifeng Guo. Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Translational Neurodegeneration 2023; 12(1) doi: 10.1186/s40035-023-00392-8
|
| 275 |
Jun Wen, Yue Wu, Fengfeng Zhang, Yanchu Wang, Aifen Yang, Wenwen Lu, Xiaofeng Zhao, Huaping Tao. Neonatal hypoxia leads to impaired intestinal function and changes in the composition and metabolism of its microbiota. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-00041-2
|
| 276 |
Anna Onisiforou, George M Spyrou. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches. Briefings in Bioinformatics 2021; 22(6) doi: 10.1093/bib/bbab141
|
| 277 |
Bo Ram Beck, Gun-Seok Park, Do Yeun Jeong, Yong Hyun Lee, Sunghoon Im, Won Ho Song, Jihee Kang. Multidisciplinary and Comparative Investigations of Potential Psychobiotic Effects of Lactobacillus Strains Isolated From Newborns and Their Impact on Gut Microbiota and Ileal Transcriptome in a Healthy Murine Model. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00269
|
| 278 |
Arielle Planchette, Ivana Gantar, Jules Scholler, Aleksander Sobolewski, Yoseline Cabara, Karol Wojcicki, Corinne Brana, Tony Durand, Philippe Naveilhan, Gaël Barthet, Michel Neunlist, Stéphane Pagès, Michalina J. Gora. enGLOW 3D microscopy of the enteric nervous system in cleared human and mouse gut. Communications Biology 2026; 9(1) doi: 10.1038/s42003-026-09643-6
|
| 279 |
Shima Mehrabadi, Seyed Shahabeddin Sadr. Assessment of Probiotics Mixture on Memory Function, Inflammation Markers, and Oxidative Stress in an Alzheimer's Disease Model of Rats. Iranian Biomedical Journal 2020; 24(4) doi: 10.29252/ibj.24.4.220
|
| 280 |
Vibeke D. Valderhaug, Kristine Heiney, Ola Huse Ramstad, Geir Bråthen, Wei-Li Kuan, Stefano Nichele, Axel Sandvig, Ioanna Sandvig. Early functional changes associated with alpha-synuclein proteinopathy in engineered human neural networks. American Journal of Physiology-Cell Physiology 2021; 320(6) doi: 10.1152/ajpcell.00413.2020
|
| 281 |
Masaru Tanaka. Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation. Cells 2025; 14(15) doi: 10.3390/cells14151161
|
| 282 |
Hao Deng, Xiaolong Li, Dihu Wang, Youheng Peng, Maoyu Wang, Hao Liang, Yang Wu, Linglong Xiao, Wei Pan, Wei Wang, Senlin Yin. Deep brain stimulation as neuroimmune-metabolic modulation in Parkinson’s disease and beyond: tissue response, glial remodeling, and disease modification. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1940474
|
| 283 |
Huajun Pan, Zhigang Liu. Molecular Nutrition and Mitochondria. 2023; doi: 10.1016/B978-0-323-90256-4.00024-2
|
| 284 |
Subhashree Priyadarsini, Moumita Sahoo, Swetapadma Sahu, Rasu Jayabalan, Monalisa Mishra. An infection of Enterobacter ludwigii affects development and causes age-dependent neurodegeneration in Drosophila melanogaster. Invertebrate Neuroscience 2019; 19(4) doi: 10.1007/s10158-019-0233-y
|
| 285 |
Qingchun Lei, Tingting Wu, Jin Wu, Xiaogang Hu, Yingxia Guan, Ying Wang, Jinyuan Yan, Guolin Shi. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Molecular Medicine Reports 2021; 24(4) doi: 10.3892/mmr.2021.12374
|
| 286 |
Kejia Xu, Qiong Huang, Ying Lyu, Shuyan Wang, Yinzhong Lu, Gang Qian. Phosphatidylserine improves aging sepsis survival, modulates gut microbiome, and prevents sepsis-associated encephalopathy. Biomedicine & Pharmacotherapy 2024; 178 doi: 10.1016/j.biopha.2024.117200
|
| 287 |
Aaron Lerner, Torsten Matthias. Don’t forget the exogenous microbial transglutaminases: it is immunogenic and potentially pathogenic. AIMS Biophysics 2016; 3(4) doi: 10.3934/biophy.2016.4.546
|
| 288 |
Briana R. De Miranda, J. Timothy Greenamyre. Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease. Environmental Science: Processes & Impacts 2020; 22(3) doi: 10.1039/C9EM00578A
|
| 289 |
Saravana Babu Chidambaram, Musthafa Mohamed Essa, A.G. Rathipriya, Muhammed Bishir, Bipul Ray, Arehally M. Mahalakshmi, A.H. Tousif, Meena K. Sakharkar, Rajpal Singh Kashyap, Robert P. Friedland, Tanya M. Monaghan. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacology & Therapeutics 2022; 231 doi: 10.1016/j.pharmthera.2021.107988
|
| 290 |
Stephan Klatt, James D. Doecke, Anne Roberts, Berin A. Boughton, Colin L. Masters, Malcolm Horne, Blaine R. Roberts. A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease. npj Parkinson's Disease 2021; 7(1) doi: 10.1038/s41531-021-00239-x
|
| 291 |
Siyu Dong, Mei Sun, Chuan He, Hong Cheng. Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective. Brain Research Bulletin 2022; 183 doi: 10.1016/j.brainresbull.2022.02.015
|
| 292 |
Xuejing Wang, Shiyin Li, Guangcheng Zhong, Ting Zhang, Qini Chen, Shangwen Jing, Shan Liu, Junhui Liu, Qi Wang. The therapeutic potential of saponins for neurological diseases via the gut-brain axis. Chinese Journal of Natural Medicines 2026; 24(9) doi: 10.1016/S1875-5364(26)61203-4
|
| 293 |
Arman Rahmim, Martin A. Lodge, Nicolas A. Karakatsanis, Vladimir Y. Panin, Yun Zhou, Alan McMillan, Steve Cho, Habib Zaidi, Michael E. Casey, Richard L. Wahl. Dynamic whole-body PET imaging: principles, potentials and applications. European Journal of Nuclear Medicine and Molecular Imaging 2019; 46(2) doi: 10.1007/s00259-018-4153-6
|
| 294 |
|
| 295 |
Rebekah Rajiah, Kazuya Takahashi, Qasim Aziz, James K. Ruffle. Brain effect of transcutaneous vagal nerve stimulation: A meta‐analysis of neuroimaging evidence. Neurogastroenterology & Motility 2024; 36(8) doi: 10.1111/nmo.14484
|
| 296 |
Tariq Ismail, Sabrina Donati-Zeppa, Saeed Akhtar, Eleonora Turrini, Anam Layla, Piero Sestili, Carmela Fimognari. Coffee in cancer chemoprevention: an updated review. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(1) doi: 10.1080/17425255.2021.1839412
|
| 297 |
Ying Yang, Shili Liu, Yihua Wang, Zhibin Wang, Wenyu Ding, Xiaoyuan Sun, Kunlun He, Qiang Feng, Xiandang Zhang. Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis. Aging 2020; 12(13) doi: 10.18632/aging.103399
|
| 298 |
Inês C. Brás, Tiago F. Outeiro. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells 2021; 10(2) doi: 10.3390/cells10020375
|
| 299 |
Ying Chen, Dongwei Wang, Yinsheng Liao, Gang Zuo, Xiaojun Lu. The complex relationship between the microbiota-gut-brain axis and neurodegenerative diseases and future perspectives. Discover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00135-2
|
| 300 |
Elisabetta Damiani, Rosita Gabbianelli. Early Life Origins of Ageing and Longevity. Healthy Ageing and Longevity 2019; 9 doi: 10.1007/978-3-030-24958-8_9
|
| 301 |
Bang-rong Wei, Yu-jia Zhao, Yu-feng Cheng, Chun Huang, Feng Zhang. Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing 2024; 21(1) doi: 10.1186/s12979-023-00404-1
|
| 302 |
Wei Tao, Yanren Zhang, Bingbin Wang, Saiqun Nie, Li Fang, Jian Xiao, Yanqing Wu. Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance. Journal of Advanced Research 2025; 69 doi: 10.1016/j.jare.2024.03.023
|
| 303 |
Pengfei Fu, Meng Gao, Ken Kin Lam Yung. Association of Intestinal Disorders with Parkinson’s Disease and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. ACS Chemical Neuroscience 2020; 11(3) doi: 10.1021/acschemneuro.9b00607
|
| 304 |
Amaia Iriondo-DeHond, José Antonio Uranga, Maria Dolores del Castillo, Raquel Abalo. Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis. Nutrients 2020; 13(1) doi: 10.3390/nu13010088
|
| 305 |
Mohamed A. Farag, Martin von Bergen, Basma M. Saleh, Masun Nabhan Homsi, Mohamed S. Abd El-Al. How do green and black coffee brews and bioactive interaction with gut microbiome affect its health outcomes? Mining evidence from mechanistic studies, metagenomics and clinical trials. Trends in Food Science & Technology 2021; 118 doi: 10.1016/j.tifs.2021.11.004
|
| 306 |
Jessica Y. Vargas, Clara Grudina, Chiara Zurzolo. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease. Ageing Research Reviews 2019; 50 doi: 10.1016/j.arr.2019.01.012
|
| 307 |
Yumna El-Hakim, Kathiresh Kumar Mani, Amir Eldouh, Sivani Pandey, Maria T. Grimaldo, Alan Dabney, Rachel Pilla, Farida Sohrabji. Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats. Biology of Sex Differences 2021; 12(1) doi: 10.1186/s13293-020-00352-1
|
| 308 |
奕玮 聂. To Explore the Mechanism of Alzheimer’s Disease Based on Brain-Gut Axis Theory. Hans Journal of Biomedicine 2023; 13(02) doi: 10.12677/HJBM.2023.132013
|
| 309 |
Carley Rusch, Matthew Beke, Carmelo Nieves, Volker Mai, Tamara Stiep, Tracy Tholanikunnel, Adolfo Ramirez-Zamora, Christopher W. Hess, Bobbi Langkamp-Henken. Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial. Nutrients 2024; 16(17) doi: 10.3390/nu16172946
|
| 310 |
Bei Gao, Liang Chi, Pengcheng Tu, Nan Gao, Kun Lu. The Carbamate Aldicarb Altered the Gut Microbiome, Metabolome, and Lipidome of C57BL/6J Mice. Chemical Research in Toxicology 2019; 32(1) doi: 10.1021/acs.chemrestox.8b00179
|
| 311 |
Peng-Ning Wu, Shuai Xiong, Peng Zhong, Wan-Qing Yang, Min Chen, Tai-Chun Tang. Global trends in research on irritable bowel syndrome and the brain–gut axis: Bibliometrics and visualization analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.956204
|
| 312 |
Onur Çakıcı, Nektarios Tavernarakis. The role of glia autophagy in CNS homeostasis, ageing and disease. Geromedicine 2026; doi: 10.70401/Geromedicine.2026.0019
|
| 313 |
Yuxuan He, Jingyi Wang, Chunmiao Ying, Weixiao Liang, Zaitian Yin, Jing Gao, Boqiao Wang, Xiaohui Zhao, Yunke Zhang. The regulatory mechanisms of active ingredients in traditional Chinese medicine for inflammation in Parkinson disease: A review. Medicine 2025; 104(42) doi: 10.1097/MD.0000000000044392
|
| 314 |
Nicola Principi, Rita Cozzali, Edoardo Farinelli, Andrea Brusaferro, Susanna Esposito. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection 2018; 76(2) doi: 10.1016/j.jinf.2017.12.013
|
| 315 |
Jigar Bhagatwala, Satish S.C. Rao. Clinical and Basic Neurogastroenterology and Motility. 2020; doi: 10.1016/B978-0-12-813037-7.00024-8
|
| 316 |
Eneidy Piña Mojica, Joao Victor Ribeiro, Felipe Fregni. Noise as Medicine: The Role of Microbial and Electrical Noise in Restoring Neuroimmune Tolerance Through Stochastic Resonance. NeuroSci 2025; 6(4) doi: 10.3390/neurosci6040118
|
| 317 |
Clara Bullich, Ali Keshavarzian, Johan Garssen, Aletta Kraneveld, Paula Perez‐Pardo. Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis. Movement Disorders Clinical Practice 2019; 6(8) doi: 10.1002/mdc3.12840
|
| 318 |
An-Di Chen, Jia-Xin Cao, Hai-Chao Chen, Hong-Li Du, Xiao-Xia Xi, Jing Sun, Jie Yin, Yu-Hong Jing, Li-Ping Gao. Rotenone aggravates PD-like pathology in A53T mutant human α-synuclein transgenic mice in an age-dependent manner. Frontiers in Aging Neuroscience 2022; 14 doi: 10.3389/fnagi.2022.842380
|
| 319 |
Valentina Caputi, Maria Cecilia Giron. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease. International Journal of Molecular Sciences 2018; 19(6) doi: 10.3390/ijms19061689
|
| 320 |
Leszek Szablewski. Human Gut Microbiota in Health and Alzheimer’s Disease. Journal of Alzheimer’s Disease 2018; 62(2) doi: 10.3233/JAD-170908
|
| 321 |
Yusuke Kawashima, Eiichiro Watanabe, Taichi Umeyama, Daisuke Nakajima, Masahira Hattori, Kenya Honda, Osamu Ohara. Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis. International Journal of Molecular Sciences 2019; 20(23) doi: 10.3390/ijms20235932
|
| 322 |
Rebecca L. Wallings, Mary K. Herrick, Malú Gámez Tansey. LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00443
|
| 323 |
Sanaz Salaramoli, Hamid Reza Joshaghani, Seyed Isaac Hashemy, Mamede de Carvalho. Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson’s Disease. Neurology Research International 2023; 2023 doi: 10.1155/2023/3555418
|
| 324 |
Zainab Abdullah Khaleel, Zahraa Amer Hashim, Vildan Celiksoy. Encountering the potentials of probiotics against urogenital tract infections in females. Journal of Research in Pharmacy 2026; 30(1) doi: 10.12991/jrespharm.1667840
|
| 325 |
Zhonglei Wang, Yueran Cui, Dongpu Li, Lili Yan, Shihan Zhu, Xiaoming Ma, Zongzong Lu, Chenfeng Li, Juan Feng, Wei Yuan, Xin He. Alternate-day fasting ameliorates α-synuclein pathology and suppresses inflammation via the gut-brain axis in an MPTP-induced subacute mouse model of Parkinson’s disease. npj Biofilms and Microbiomes 2025; 11(1) doi: 10.1038/s41522-025-00855-y
|
| 326 |
Devaraja Gayathri, Mahanthesh Vasudha, Chakra Siddappa Prashantkumar. Microbiome-Gut-Brain Axis. 2022; doi: 10.1007/978-981-16-1626-6_11
|
| 327 |
Shui Yu, Hai-rong Peng, Yu-kai Zhang, Yan-qing Yin, Jia-wei Zhou. Central dopaminergic control of cell proliferation in the colonic epithelium. Neuroscience Research 2022; 180 doi: 10.1016/j.neures.2022.02.006
|
| 328 |
Eamonn M. M. Quigley. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Current Neurology and Neuroscience Reports 2017; 17(12) doi: 10.1007/s11910-017-0802-6
|
| 329 |
Yogesh Singh, Mohamed El-Hadidi, Jakob Admard, Zinah Wassouf, Julia M. Schulze-Hentrich, Ursula Kohlhofer, Leticia Quintanilla-Martinez, Daniel Huson, Olaf Riess, Nicolas Casadei. Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease. Frontiers in Neuroscience 2019; 13 doi: 10.3389/fnins.2019.01032
|
| 330 |
Mark Pimentel, Richard J. Saad, Millie D. Long, Satish S. C. Rao. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology 2020; 115(2) doi: 10.14309/ajg.0000000000000501
|
| 331 |
Samuel Strader, Andrew B. West. The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's disease. Biochemical Society Transactions 2023; 51(2) doi: 10.1042/BST20201091
|
| 332 |
Yoona Kim, Peter Clifton. Curcumin, Cardiometabolic Health and Dementia. International Journal of Environmental Research and Public Health 2018; 15(10) doi: 10.3390/ijerph15102093
|
| 333 |
Paula Perez-Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease. Current Behavioral Neuroscience Reports 2017; 4(4) doi: 10.1007/s40473-017-0129-2
|
| 334 |
Azar Rahi, Erfaneh Jafari, Reza Azizian, Mohammad Reza Mohammadi, Atousa Razmfarsa, Sara Shakeri Hosseinabad, Masoud Hamidi. Exploring the Gut-Brain Connection: The Role of Microbiota in Alzheimer’s Disease Pathogenesis. Dementia and Neurocognitive Disorders 2026; 25(1) doi: 10.12779/dnd.2026.25.1.1
|
| 335 |
Sergiu Groppa, Alfonso Fasano, Daniele Urso, Xinjie Yang, Bogdan Popescu, Peter Klivenyi, Teus van Laar, Wolfgang Jost, Pedro J. Garcia-Ruiz, Roongroj Bhidayasiri, Tiago F. Outeiro. Disease modification in advanced Parkinson’s disease: a review and roadmap for paving the way for next-generation interventions. Journal of Neural Transmission 2026; doi: 10.1007/s00702-026-03208-x
|
| 336 |
Jie-jun Zhou, Lei Chun, Jian-feng Liu. A Comprehensive Understanding of Dietary Effects on C. elegans Physiology. Current Medical Science 2019; 39(5) doi: 10.1007/s11596-019-2091-6
|
| 337 |
Michal Lubomski, Ai Huey Tan, Shen-Yang Lim, Andrew J. Holmes, Ryan L. Davis, Carolyn M. Sue. Parkinson’s disease and the gastrointestinal microbiome. Journal of Neurology 2020; 267(9) doi: 10.1007/s00415-019-09320-1
|
| 338 |
Qihong Liu, Yunfeng Luo, Xiao Ke, Zewei Sun. Interaction between the Gut Microbiota and Intestinal Motility. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/3240573
|
| 339 |
B. Bonaz. The gut-brain axis in Parkinson's disease. Revue Neurologique 2024; 180(1-2) doi: 10.1016/j.neurol.2023.11.004
|
| 340 |
Rengasamy Balakrishnan, Shin-Il Kang, Ji-Yeon Lee, Yang-Kook Rho, Byoung-Kook Kim, Dong-Kug Choi. Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications. Aging and disease 2024; doi: 10.14336/AD.2024.1362
|
| 341 |
Allison L. Richards, Michael B. Burns, Adnan Alazizi, Luis B. Barreiro, Roger Pique-Regi, Ran Blekhman, Francesca Luca, Jack A. Gilbert. Genetic and Transcriptional Analysis of Human Host Response to Healthy Gut Microbiota. mSystems 2016; 1(4) doi: 10.1128/mSystems.00067-16
|
| 342 |
Kristen D. Pawlowski, Brian T. David, Richard G. Fessler. Spinal Cord–Gut–Immune Axis and Its Implications Regarding Therapeutic Development for Spinal Cord Injury. Journal of Neurotrauma 2023; 40(9-10) doi: 10.1089/neu.2022.0264
|
| 343 |
Sara Ayman Moustafa, Shrouk Mohamed, Abdelhameed Dawood, Jihan Azar, Ekramy Elmorsy, Noura A. M. Rizk, Mohamed Salama. Gut brain axis: an insight into microbiota role in Parkinson’s disease. Metabolic Brain Disease 2021; 36(7) doi: 10.1007/s11011-021-00808-2
|
| 344 |
Peilin Sun, Lei Su, Hua Zhu, Xue Li, Yaxi Guo, Xiaopeng Du, Ling Zhang, Chuan Qin. Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease. Microorganisms 2021; 9(11) doi: 10.3390/microorganisms9112281
|
| 345 |
Marie Rose Frangieh, Martine Saad, Nour Fattouh, Simona Sawan. Antibiotics and nanoparticles in Parkinson’s disease: From gut microbiota dysbiosis to neuroprotection and targeted nanotherapies. Biomedicine & Pharmacotherapy 2026; 203 doi: 10.1016/j.biopha.2026.119903
|
| 346 |
Adela Ciobanu, Ioana Ionita, Mihaela Buleandra, Iulia David, Dana Popa, Anton Ciucu, Magdalena Budisteanu. Current advances in metabolomic studies on non‑motor psychiatric manifestations of Parkinson's disease (Review). Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10443
|
| 347 |
Mohd F. Khan, Sugato Banerjee. Comprehensive Gut Microbiota. 2022; doi: 10.1016/B978-0-12-819265-8.00098-X
|
| 348 |
Saima Khatoon, Nida Kalam, Summya Rashid, Gulnaz Bano. Effects of gut microbiota on neurodegenerative diseases. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1145241
|
| 349 |
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko. The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms221810028
|
| 350 |
Laura Mitrea, Silvia-Amalia Nemeş, Katalin Szabo, Bernadette-Emőke Teleky, Dan-Cristian Vodnar. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.813204
|
| 351 |
Kai Takahashi, Hiroshi Nishiwaki, Mikako Ito, Kazuhiro Iwaoka, Kenta Takahashi, Yoshio Suzuki, Keita Taguchi, Kanako Yamahara, Yoshio Tsuboi, Kenichi Kashihara, Masaaki Hirayama, Kinji Ohno, Tetsuya Maeda. Altered gut microbiota in Parkinson's disease patients with motor complications. Parkinsonism & Related Disorders 2022; 95 doi: 10.1016/j.parkreldis.2021.12.012
|
| 352 |
Weiying Ren, Jiayu Wu, Li Li, Y. Lu, Y. Shao, Y. Qi, B. Xu, Y. He, Yu Hu. Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats. The Journal of nutrition, health and aging 2018; 22(6) doi: 10.1007/s12603-018-1022-8
|
| 353 |
George Tetz, Stuart M. Brown, Yuhan Hao, Victor Tetz. Parkinson’s disease and bacteriophages as its overlooked contributors. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29173-4
|
| 354 |
Agata Mulak. A controversy on the role of short‐chain fatty acids in the pathogenesis of Parkinson's disease. Movement Disorders 2018; 33(3) doi: 10.1002/mds.27304
|
| 355 |
Vincent Caruso, Xubo Song, Mark Asquith, Lisa Karstens, Sean M. Gibbons. Performance of Microbiome Sequence Inference Methods in Environments with Varying Biomass. mSystems 2019; 4(1) doi: 10.1128/msystems.00163-18
|
| 356 |
Agata Mulak. An overview of the neuroendocrine system in Parkinson’s disease: what is the impact on diagnosis and treatment?. Expert Review of Neurotherapeutics 2020; 20(2) doi: 10.1080/14737175.2020.1701437
|
| 357 |
Yunlong Sun, Ning Xu, Jinzhong Liu, Tianxia Sun, Jie Li, Shuyang Xing, Yu Zhao, Bo Pang. Protective effect of ginseng protein on MPTP-induced Parkinson’s disease model mice. Natural Product Research 2026; doi: 10.1080/14786419.2026.2636160
|
| 358 |
. 2019; doi: 10.70675/a6f1ac92z3c01z4d54za8b5zabd5c827f6f5
|
| 359 |
Roger E. Kelley. The Human Hypothalamus. Contemporary Endocrinology 2021; doi: 10.1007/978-3-030-62187-2_21
|
| 360 |
O. N. Solodchuk, A. S. Fattakhova, A. V. Kichigina, K. M. Tregulova, M. A. Viktorova, A. P. Kolesnikova. Psychological predictors of reduced quality of life in adolescents with gastroenterological pathology. Meditsinskiy sovet = Medical Council 2026; (11) doi: 10.21518/ms2026-241
|
| 361 |
Ramana Kamatchi Shenthilvel, Thangavelu Arumugam Umashankar, Deenathayalan Uvarajan, Mohana Mathuraj, Manish Ravikumar. “Unfolding Parkinson’s Disease Through the Microbiome-Gut-Brain Axis”. Journal of Molecular Neuroscience 2026; 76(1) doi: 10.1007/s12031-025-02462-0
|
| 362 |
Tiago F. Outeiro, Eduardo Tolosa. How (We Think) Parkinson's disease begins. Parkinsonism & Related Disorders 2026; doi: 10.1016/j.parkreldis.2026.108943
|
| 363 |
Pingping Jin, Qiong Yao, Yanyan Zheng, Qiaowen Tong, Hua Ye, Baiqi Hu. Helicobacter pylori Infection Is Associated with Leukoaraiosis without Lesion Location Correlation. Digestive Diseases 2025; 44(1) doi: 10.1159/000549557
|
| 364 |
Sarah K. Lotz, Britanie M. Blackhurst, Katie L. Reagin, Kristen E. Funk. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Frontiers in Cellular Neuroscience 2021; 15 doi: 10.3389/fncel.2021.691136
|
| 365 |
Ovidiu-Dumitru Ilie, Alin Ciobica, Jack McKenna, Bogdan Doroftei, Ioannis Mavroudis, Tuane B. Sampaio. Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/4518023
|
| 366 |
Young-Ju Kim, Chang-Min Lee, Seongheon Kim, Jae-Won Jang, Seo-Young Lee, Seung-Hwan Lee. Risk of Parkinson’s disease after colectomy: longitudinal follow-up study using a national sample cohort. Journal of Neurology 2020; 267(2) doi: 10.1007/s00415-019-09617-1
|
| 367 |
Dhivya Venkatesan, Mahalaxmi Iyer, Arul Narayanasamy, Kamalakannan Siva, Balachandar Vellingiri. Kynurenine pathway in Parkinson's disease—An update. eNeurologicalSci 2020; 21 doi: 10.1016/j.ensci.2020.100270
|
| 368 |
Shengzhu Huang, Chenqi Zhang, Xing Xie, Yuanyuan Zhu, Qiong Song, Li Ye, Yan-Ling Hu. GRID2 Aberration Leads to Disturbance in Neuroactive Ligand-Receptor Interaction via Affecting the Species Richness and Composition of the Gut Microbes. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4133779
|
| 369 |
Sílvia Cabré, Kenneth J. O’Riordan, John F. Cryan. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis. Progress in Inflammation Research 2022; 89 doi: 10.1007/978-3-030-91051-8_11
|
| 370 |
Rafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, Gemma Navarro, Eva Martínez-Pinilla. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease. Frontiers in Aging Neuroscience 2020; 12 doi: 10.3389/fnagi.2020.00012
|
| 371 |
Sinian Li, Yiming Shao, Kanglan Li, Changmei HuangFu, Wenjie Wang, Zhou Liu, Zhiyou Cai, Bin Zhao. Vascular Cognitive Impairment and the Gut Microbiota. Journal of Alzheimer's Disease 2018; 63(4) doi: 10.3233/JAD-171103
|
| 372 |
Ketil Berstad, Johanna E.R. Berstad. Parkinson’s disease; the hibernating spore hypothesis. Medical Hypotheses 2017; 104 doi: 10.1016/j.mehy.2017.05.022
|
| 373 |
Donatella Tesei, Anna Jewczynko, Anne Lynch, Camilla Urbaniak. Understanding the Complexities and Changes of the Astronaut Microbiome for Successful Long-Duration Space Missions. Life 2022; 12(4) doi: 10.3390/life12040495
|
| 374 |
Ipek Balikci Cicek, Zeynep Kucukakcali, Birgul Deniz, Fatma Ebru Algül. An Explainable Approach to Parkinson’s Diagnosis Using the Contrastive Explanation Method—CEM. Diagnostics 2025; 15(16) doi: 10.3390/diagnostics15162069
|
| 375 |
Jing Liu, Fei Xu, Zhiyan Nie, Lei Shao. Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.570658
|
| 376 |
Wenyu Dai, Jieyu Liu, Yan Qiu, Ziwei Teng, Sujuan Li, Hui Yuan, Jing Huang, Hui Xiang, Hui Tang, Bolun Wang, Jindong Chen, Haishan Wu. Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893567
|
| 377 |
Xin Wang, Deming Jiang, Tianxiong Li, Xiao Zhang, Ran Wang, Song Gao, Fengyi Yang, Yan Wang, Qi Tian, Chunrong Xie, Jinghong Liang. Association between microbiological risk factors and neurodegenerative disorders: An umbrella review of systematic reviews and meta-analyses. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.991085
|
| 378 |
Ying Dong, Pan Wang, Junling Lin, Chunming Han, Jie Jiao, Kun Zuo, Mulei Chen, Xinchun Yang, Jun Cai, He Jiang, Xiheng Guo, Jing Li. Characterization of fecal metabolome changes in patients with obstructive sleep apnea. Journal of Clinical Sleep Medicine 2022; 18(2) doi: 10.5664/jcsm.9668
|
| 379 |
Kelly Jimin Park, Yao Gao. Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials. Frontiers in Neuroscience 2024; 18 doi: 10.3389/fnins.2024.1481390
|
| 380 |
V. Andreozzi, S. Cuoco, M. Balestrieri, F. Fierro, N. Ferrara, R. Erro, M. Di Filippo, G. Barbella, M. C. Memoli, A. Silvestri, M. Squillante, S. Guglielmetti, P. Barone, P. Iovino, M. T. Pellecchia. Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson’s disease: results from an open label single-arm study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74400-w
|
| 381 |
Nilabha Mukherjea, Ashwin Khandelwal, Rohit Saluja, Neetu Kalra. The Role of the human microbiome in neurodegenerative diseases: A Perspective. Current Genetics 2025; 71(1) doi: 10.1007/s00294-025-01319-8
|
| 382 |
Rijhul Lahariya, Gargee Anand, Bandana Kumari, Ketan Priyadarshi. Postbiotics and the gut–brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging. Journal of Neuroimmunology 2026; 413 doi: 10.1016/j.jneuroim.2026.578870
|
| 383 |
R. R. Tyutina, A. A. Pilipovich, V. L. Golubev, Al. B. Danilov. Microbiota and Parkinson's disease (overview). Medical alphabet 2020; (1) doi: 10.33667/2078-5631-2020-1-10-14
|
| 384 |
Precision Medicine in Neurodegenerative Disorders, Part II. Handbook of Clinical Neurology 2023; 193 doi: 10.1016/B978-0-323-85555-6.00006-0
|
| 385 |
Kurt A. Jellinger. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders. Journal of Neural Transmission 2019; 126(8) doi: 10.1007/s00702-019-02028-6
|
| 386 |
Soumya Sundaram, Dinoop Korol Ponnambath, Sruthi S. Nair. Human Microbiome. 2022; doi: 10.1007/978-981-16-7672-7_7
|
| 387 |
. 2018; doi: 10.70675/ab1bac8ezd1d7z4faczafedzd5f7efbfe78c
|
| 388 |
Natasa Kustrimovic, Sahar Balkhi, Giorgia Bilato, Lorenzo Mortara. Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases. International Journal of Molecular Sciences 2024; 25(22) doi: 10.3390/ijms252212164
|
| 389 |
Wei Qin, Yirong Shi, Weimei Chen, Xiaokang Jia, Tetsuya Asakawa. Can kynurenine pathway be considered as a next-generation therapeutic target for Parkinson's disease? An update information. BioScience Trends 2022; 16(4) doi: 10.5582/bst.2022.01352
|
| 390 |
Yiwei Qian, Xiaodong Yang, Shaoqing Xu, Chunyan Wu, Nan Qin, Sheng-Di Chen, Qin Xiao. Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson’s Disease. Frontiers in Aging Neuroscience 2018; 10 doi: 10.3389/fnagi.2018.00156
|
| 391 |
Guadalupe Vidal-Martinez, Brandon Chin, Cynthia Camarillo, Gloria V. Herrera, Barbara Yang, Irene Sarosiek, Ruth G. Perez. A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. Journal of Parkinson’s Disease 2019; 10(1) doi: 10.3233/JPD-191693
|
| 392 |
Madelyn C. Houser, Malú G. Tansey. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?. npj Parkinson's Disease 2017; 3(1) doi: 10.1038/s41531-016-0002-0
|
| 393 |
Boyan Wang, Di Ma, Na Li, Tianfei Luo. The application of fecal microbiota transplantation in Parkinson’s disease. Frontiers in Aging Neuroscience 2025; 17 doi: 10.3389/fnagi.2025.1713899
|
| 394 |
Xianmin Lu, Qi Liu, Ya Deng, Jiangbo Wu, Xingyi Mu, Xiaoxu Yang, Ting Zhang, Chen Luo, Zhuo Li, Siqi Tang, Yanxia Hu, Qian Du, Jingyu Xu, Rui Xie. Research progress on the roles of dopamine and dopamine receptors in digestive system diseases. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18154
|
| 395 |
Shuo Yang, Xiaojia Sun, Dianfeng Liu, Yiming Zhang, Xiyu Gao, Jiangmei He, Mingchi Cui, Shoupeng Fu, Dewei He. Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. Food & Function 2024; 15(18) doi: 10.1039/D4FO02167C
|
| 396 |
Jacek Baj, Alicja Forma, Wojciech Flieger, Izabela Morawska, Adam Michalski, Grzegorz Buszewicz, Elżbieta Sitarz, Piero Portincasa, Gabriella Garruti, Michał Flieger, Grzegorz Teresiński. Helicobacter pylori Infection and Extragastric Diseases—A Focus on the Central Nervous System. Cells 2021; 10(9) doi: 10.3390/cells10092191
|
| 397 |
Hongxiang Zhao, Meiyan Sun, Yue Zhang, Wenwen Kong, Lulu Fan, Kaifang Wang, Qing Xu, Baiyan Chen, Jianxin Dong, Yanan Shi, Zhengyan Wang, ShiQi Wang, Xiaoli Zhuang, Qi Li, Feihong Lin, Xinyu Yao, WenBo Zhang, Chang Kong, Rui Zhang, Dayun Feng, Xiaoyong Zhao. Connecting the Dots: The Cerebral Lymphatic System as a Bridge Between the Central Nervous System and Peripheral System in Health and Disease. Aging and disease 2024; 15(1) doi: 10.14336/AD.2023.0516
|
| 398 |
Yanpei Huang, Haiming Chen, Weijun Chen, Wenxue Chen, Qiuping Zhong, Jianfei Pei, Ming Zhang, Guido R. M. M. Haenen. Development and Application of Polyphenols in Food: A Comprehensive Review. Food Frontiers 2025; 6(3) doi: 10.1002/fft2.533
|
| 399 |
Priya Bindal, Swati Kaushal, Charan Singh, Arti Singh. Microbiota-Gut-Brain Axis and CNS Disorders. 2025; doi: 10.1016/B978-0-443-21680-0.00005-5
|
| 400 |
Wu Zhou, Lihong Zhao, Zelu Mao, Zhihua Wang, Zhixiong Zhang, Meihua Li. Bidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles. Cellular and Molecular Neurobiology 2023; 43(6) doi: 10.1007/s10571-023-01345-5
|
| 401 |
Yaoyu Pu, Lijia Chang, Youge Qu, Siming Wang, Kai Zhang, Kenji Hashimoto. Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain. Aging 2019; 11(17) doi: 10.18632/aging.102221
|
| 402 |
Shakshi Sharma, Anupam Awasthi, Shamsher Singh. Altered gut microbiota and intestinal permeability in Parkinson’s disease: Pathological highlight to management. Neuroscience Letters 2019; 712 doi: 10.1016/j.neulet.2019.134516
|
| 403 |
Li-song Zhu, Jing Wang, Jun Lu, Hui-qian Liu, Xiao-qing Jin, Zhen-yu Shu, Li-hong Li. Effect of hemodynamic characteristic changes of the carotid artery on 6-OHDA-induced Parkinson’s disease model rats treated by Gut-acupuncture. Journal of King Saud University - Science 2020; 32(6) doi: 10.1016/j.jksus.2020.03.038
|
| 404 |
Xi Jia, Qin Wang, Meilingzi Liu, Jia-yuan Ding. The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment. Frontiers in Neurology 2024; 15 doi: 10.3389/fneur.2024.1415463
|
| 405 |
Suzanne T. Witt, Olga Bednarska, Åsa V. Keita, Adriane Icenhour, Michael P. Jones, Sigrid Elsenbruch, Johan D. Söderholm, Maria Engström, Emeran A. Mayer, Susanna Walter. Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome. NeuroImage: Clinical 2019; 21 doi: 10.1016/j.nicl.2018.11.012
|
| 406 |
Xin Xie, Xiaoguang Luo, Mingliang Xie. Association between Parkinson's disease and risk of colorectal cancer. Parkinsonism & Related Disorders 2017; 35 doi: 10.1016/j.parkreldis.2016.11.011
|
| 407 |
Fenfa Li, Xichun Peng, Wenzhi Li. The interaction between various food components and intestinal microbiota improves human health through the gut–X axis: independently or synergistically. Food & Function 2025; 16(6) doi: 10.1039/D4FO04430D
|
| 408 |
Jinglu Hu, Wencheng Jiao, Ziyan Tang, Chunqing Wang, Qi Li, Meng Wei, Shiyong Song, Lina Du, Yiguang Jin. Quercetin inclusion complex gels ameliorate radiation-induced brain injury by regulating gut microbiota. Biomedicine & Pharmacotherapy 2023; 158 doi: 10.1016/j.biopha.2022.114142
|
| 409 |
Michael Ganci, Emra Suleyman, Henry Butt, Michelle Ball. The role of the brain–gut–microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders. Brain and Behavior 2019; 9(11) doi: 10.1002/brb3.1408
|
| 410 |
Lan Yu, Xiaolu Hu, Rongrong Xu, Yimeng Zhao, Lijuan Xiong, Jiaxuan Ai, Xing Wang, Xiaoqing Chen, Yinying Ba, Zhikai Xing, Chongye Guo, Shuangli Mi, Xia Wu. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson’s disease rats. Journal of Ethnopharmacology 2024; 322 doi: 10.1016/j.jep.2023.117628
|
| 411 |
Cesar de la Fuente-Nunez, Beatriz Torres Meneguetti, Octávio Luiz Franco, Timothy K. Lu. Neuromicrobiology: How Microbes Influence the Brain. ACS Chemical Neuroscience 2018; 9(2) doi: 10.1021/acschemneuro.7b00373
|
| 412 |
Cai-xia Gong, Cheng Ma, Dejene Disasa Irge, Shu-min Li, Si-min Chen, Shi-xian Zhou, Xin-xiu Zhao, Han-yu Li, Jin-you Li, Yun-mei Yang, Lan Xiang, Qin Zhang. Gastrodia elata and parishin ameliorate aging induced ‘leaky gut’ in mice: Correlation with gut microbiota. Biomedical Journal 2023; 46(4) doi: 10.1016/j.bj.2022.07.001
|
| 413 |
Nina Gorlé, Eva Bauwens, Freddy Haesebrouck, Annemieke Smet, Roosmarijn E. Vandenbroucke. Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.584165
|
| 414 |
Małgorzata Anna Marć, Rafał Jastrząb, Jennifer Mytych. Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders. Nutrients 2022; 14(19) doi: 10.3390/nu14193967
|
| 415 |
Jun-Ji Cui, Ze-Yun Huang, Yi-Hang Xie, Jun-Bin Wu, Guang-Hui Xu, Cheng-Fu Li, Man-Man Zhang, Li-Tao Yi. Gut microbiota mediated inflammation, neuroendocrine and neurotrophic functions involved in the antidepressant-like effects of diosgenin in chronic restraint stress. Journal of Affective Disorders 2023; 321 doi: 10.1016/j.jad.2022.10.045
|
| 416 |
Florina Ruța, Mirela Pribac, Elena Mardale, Sara Suciu, Raluca Maior, Simona Bogdan, Călin Avram. Associations between Gut Microbiota Dysbiosis and Other Risk Factors in Women with a History of Urinary Tract Infections. Nutrients 2024; 16(11) doi: 10.3390/nu16111753
|
| 417 |
F. Khan, S.F. Oloketuyi. A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota. Journal of Applied Microbiology 2017; 122(2) doi: 10.1111/jam.13327
|
| 418 |
David J. McGee, Xiao-Hong Lu, Elizabeth A. Disbrow. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson’s Disease. Journal of Parkinson’s Disease 2018; 8(3) doi: 10.3233/JPD-181327
|
| 419 |
|
| 420 |
Monika Pliszka, Leszek Szablewski. Human Gut Microbiota: Friend or Foe?. OBM Hepatology and Gastroenterology 2020; 4(03) doi: 10.21926/obm.hg.2003050
|
| 421 |
Shirley H. F. Lee, Siti R. Ahmad, Ya C. Lim, Ihsan N. Zulkipli. The Use of Probiotic Therapy in Metabolic and Neurological Diseases. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.887019
|
| 422 |
Simona Cannas, Barbara Tonini, Benedetta Belà, Roberta Di Prinzio, Giulia Pignataro, Daniele Di Simone, Alessandro Gramenzi. Effect of a novel nutraceutical supplement (Relaxigen Pet dog) on the fecal microbiome and stress-related behaviors in dogs: A pilot study. Journal of Veterinary Behavior 2021; 42 doi: 10.1016/j.jveb.2020.09.002
|
| 423 |
Yingxian Liu, Tuoxian Tang, Hang Cai, Zhenjiang Liu. Bidirectional communication between the gut microbiota and the central nervous system. Neural Regeneration Research 2026; 21(8) doi: 10.4103/NRR.NRR-D-25-00434
|
| 424 |
Qiu-Zhu Chen, Jun-Mei Shang, Yue-Qi Jiang, Yang Yang, Cai-Xia Zang, Jing-Wei Ma, Yi-Rong Dong, Jin-Rong Wang, Ning Zhou, Xing Yang, Fang-Fang Li, Xiu-Qi Bao, Dan Zhang. Gut microbial dysbiosis aggravated Parkinson-like pathology induced by MPTP/probenecid. Physiology & Behavior 2025; 299 doi: 10.1016/j.physbeh.2025.115008
|
| 425 |
Suhas Hajare, Yogesh A. Kulkarni. Parkinson’s disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies. Brain Research 2025; 1868 doi: 10.1016/j.brainres.2025.149975
|
| 426 |
Rehab E. Abo El Gheit, Marwa M. Atef, Omnia S. El Deeb, Ghada A. Badawi, Hanan A. Alshenawy, Walaa M. Elwan, Heba M. Arakeep, Marwa N. Emam. Unique Novel Role of Adropin in a Gastric Ulcer in a Rotenone-Induced Rat Model of Parkinson’s Disease. ACS Chemical Neuroscience 2020; 11(19) doi: 10.1021/acschemneuro.0c00424
|
| 427 |
Monica Barone, Federica D’Amico, Simone Rampelli, Patrizia Brigidi, Silvia Turroni. Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging. Mechanisms of Ageing and Development 2022; 206 doi: 10.1016/j.mad.2022.111711
|
| 428 |
Jiangjiang Bi, Yifan Xu, Shiyong Li, Gaofeng Zhan, Dongyu Hua, Juan Tan, Xiaohui Chi, Hongbing Xiang, Fengjing Guo, Ailin Luo. Contribution of preoperative gut microbiota in postoperative neurocognitive dysfunction in elderly patients undergoing orthopedic surgery. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1108205
|
| 429 |
Suparna Roy Sarkar, Sugato Banerjee. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 2019; 328 doi: 10.1016/j.jneuroim.2019.01.004
|
| 430 |
Pedro L. Esquinas, Fereshteh Yousefirizi, Ian Alberts, Nicolas A. Karakatsanis, Arman Rahmim, Carlos F. Uribe. Seeing More, Treating Smarter. PET Clinics 2026; 21(1) doi: 10.1016/j.cpet.2025.09.007
|
| 431 |
Marcela Konjevod, Matea Nikolac Perkovic, Jorge Sáiz, Dubravka Svob Strac, Coral Barbas, David Rojo. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. Journal of Pharmaceutical and Biomedical Analysis 2021; 194 doi: 10.1016/j.jpba.2020.113681
|
| 432 |
Yusra Habib Khan, Aroosa Liaqat, Tauqeer Hussain Mallhi, Arooj Abid, Nasser Hadal Alotaibi, Amjad Khan. Environmental Contaminants and Neurological Disorders. Emerging Contaminants and Associated Treatment Technologies 2021; doi: 10.1007/978-3-030-66376-6_3
|
| 433 |
Henry B. Ogden, Joanne L. Fallowfield, Robert B. Child, Glen Davison, Simon C. Fleming, Robert M. Edinburgh, Simon K. Delves, Alison Millyard, Caroline S. Westwood, Joseph D. Layden. Reliability of gastrointestinal barrier integrity and microbial translocation biomarkers at rest and following exertional heat stress. Physiological Reports 2020; 8(5) doi: 10.14814/phy2.14374
|
| 434 |
Alexander M. Vaiserman, Alexander K. Koliada, Francesco Marotta. Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Research Reviews 2017; 35 doi: 10.1016/j.arr.2017.01.001
|
| 435 |
Xiaoyu Zhang, Jia Wang, Tingting Zhang, Shuqin Li, Junyu Liu, Mingyue Li, Jingyang Lu, Min Zhang, Haixia Chen. Updated Progress on Polysaccharides with Anti-Diabetic Effects through the Regulation of Gut Microbiota: Sources, Mechanisms, and Structure–Activity Relationships. Pharmaceuticals 2024; 17(4) doi: 10.3390/ph17040456
|
| 436 |
Ning Xu, Shuyang Xing, Jie Li, Bo Pang, Meichen Liu, Meiling Fan, Yu Zhao, Chun-Hua Wang. Water extract of ginseng alleviates parkinsonism in MPTP–induced Parkinson’s disease mice. PLOS ONE 2024; 19(9) doi: 10.1371/journal.pone.0296424
|
| 437 |
Antonio Di Sabatino, Marco Vincenzo Lenti, Lisa Cammalleri, Gino Roberto Corazza, Alberto Pilotto. Frailty and the gut. Digestive and Liver Disease 2018; 50(6) doi: 10.1016/j.dld.2018.03.010
|
| 438 |
Ingrid Rivera-Iñiguez, Sonia Roman, Claudia Ojeda-Granados, Panduro Arturo. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; doi: 10.1016/B978-0-12-815249-2.00040-3
|
| 439 |
Sonia González, Nuria Salazar, Sergio Ruiz-Saavedra, María Gómez-Martín, Clara G. de los Reyes-Gavilán, Miguel Gueimonde. Long-Term Coffee Consumption is Associated with Fecal Microbial Composition in Humans. Nutrients 2020; 12(5) doi: 10.3390/nu12051287
|
| 440 |
Gábor Ternák, Károly Berényi, Balázs Németh, Ágnes Szenczi, Gergely Márovics, István Kiss. Association of antibiotic-consumption patterns with the prevalence of hematological malignancies in European countries. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11569-y
|
| 441 |
Kaili Liu, Yijie He, Beila Wen, Yan Wei, Rongqiao He. Formaldehyde and Cognition. 2025; doi: 10.1007/978-981-96-7281-3_7
|
| 442 |
Andrea R. Merchak, Mary K. Herrick, Madelyn C. Houser, Cody E. Keating, Jianjun Chang, Malú Gámez Tansey. Intestinal inflammation promotes neuroinflammation and PD-associated nigrostriatal pathology independently of LRRK2 G2019S kinase activity. Frontiers in Cellular Neuroscience 2026; 20 doi: 10.3389/fncel.2026.1794784
|
| 443 |
Qiang Yue, Mingfei Cai, Bo Xiao, Qiong Zhan, Chang Zeng. The Microbiota–Gut–Brain Axis and Epilepsy. Cellular and Molecular Neurobiology 2022; 42(2) doi: 10.1007/s10571-021-01130-2
|
| 444 |
Salomón Páez-García, Daniel Hernández-Triana, Felipe Esparza-Salazar, George E. Barreto, Maria Cruz Rodriguez-Oroz, Miguel Germán Borda. Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease. Exploration of Neuroprotective Therapy 2025; 5 doi: 10.37349/ent.2025.1004129
|
| 445 |
Mohamed J. Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, Renuka Jyothi. S, Hasan Khalid Dabis, G. V. Siva Prasad, Imad Jassim Mohammad, Ahmed Adnan, Ameer Hassan Idan. The role of gut-derived short-chain fatty acids in Parkinson's disease. Neurogenetics 2024; 25(4) doi: 10.1007/s10048-024-00779-3
|
| 446 |
Arnas Kunevičius, Akshay Kumar Vijaya, Alessandro Atzeni, Jonas Mingaila, Ieva Šimoliūnė, Rapolas Jamontas, Emilija Keževičiūtė, Miguel Gueimonde, Rolandas Meškys, Daiva Baltriukienė, Silvia Arboleya, Aurelijus Burokas. Intermittent supplementation with Akkermansia muciniphila and galactooligosaccharides modulates Alzheimer’s disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice. Frontiers in Aging Neuroscience 2025; 17 doi: 10.3389/fnagi.2025.1617980
|
| 447 |
Lavanya Palanisamy, Sobiya RA, Geetanjali Devi Naorem, Angayarkanni T. Probiotics Role in Gut-Brain Axis: A Novel Insight of Microbiota Involving Neurodegenerative Disorders. Microbiology and Biotechnology Letters 2026; 54 doi: 10.48022/mbl.2512.12009
|
| 448 |
Saravana Babu Chidambaram, Annan Gopinath Rathipriya, Arehally M. Mahalakshmi, Sonali Sharma, Tousif Ahmed Hediyal, Bipul Ray, Tuladhar Sunanda, Wiramon Rungratanawanich, Rajpal Singh Kashyap, M. Walid Qoronfleh, Musthafa Mohamed Essa, Byoung-Joon Song, Tanya M. Monaghan. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022; 11(7) doi: 10.3390/cells11071239
|
| 449 |
G. B. Stefano, N. Pilonis, R. Ptacek, J. Raboch, M. Vnukova, R. M. Kream. Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. Cellular and Molecular Neurobiology 2018; 38(6) doi: 10.1007/s10571-018-0589-2
|
| 450 |
Yaqi Xue, Shasha An, Weihua Qiu, Weinan Zhang, Limin Fu, Zhiping Zhen. Exercise Changes Gut Microbiota: A New Idea to Explain that Exercise
Improves Autism. International Journal of Sports Medicine 2023; 44(07) doi: 10.1055/a-2018-2477
|
| 451 |
Vittorio Calabrese, Aurelia Santoro, Daniela Monti, Rosalia Crupi, Rosanna Di Paola, Saverio Latteri, Salvatore Cuzzocrea, Mario Zappia, James Giordano, Edward J. Calabrese, Claudio Franceschi. Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biology and Medicine 2018; 115 doi: 10.1016/j.freeradbiomed.2017.10.379
|
| 452 |
Audrey Labarre, Ericka Guitard, Gilles Tossing, Anik Forest, Eric Bareke, Marjorie Labrecque, Martine Tétreault, Matthieu Ruiz, J. Alex Parker. Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-04295-8
|
| 453 |
Jiaqi Xiao, Xuan Qin, WenTao Chen, Xinyu Que, Yaoyao Ma, Wentao Huang, Haoxiang Ou, Yongfen Bao, Lihua Qu, Shigang Shan. Immunoinflammation and post-translational modifications in the aging process. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06892-7
|
| 454 |
Shuyuan Guo, Zhuxia Zhang, Bingxuan Xu, Mengxin Wang, Taojian Fan, Xinliang Zhong, Azhen Hu, Die Hu, Lan Luo, Shuping Lin, Linlin Wang, Rongquan Yao, Jiabao Huang, Huiying Hu, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng. Black Phosphorus Microbubbles Combined with Ultrasound for Treating Parkinson's Disease. Advanced Therapeutics 2024; 7(5) doi: 10.1002/adtp.202300254
|
| 455 |
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Saurabh Bhatia, Ahmed Al-Harrasi, Gokhan Zengin, Adrian Gheorghe Bumbu, Felicia Liana Andronie-Cioara, Aurelia Cristina Nechifor, Daniela Gitea, Alexa Florina Bungau, Mirela Marioara Toma, Simona Gabriela Bungau. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson’s Disorder and Therapeutic Implications. International Journal of Molecular Sciences 2021; 22(13) doi: 10.3390/ijms22136737
|
| 456 |
Zohreh Sattar, Javad Asili. Probiotics and Plant Extracts in the Gut–Brain Axis: Mechanisms, Interactions, and Clinical Perspectives. Probiotics and Antimicrobial Proteins 2026; doi: 10.1007/s12602-026-11152-1
|
| 457 |
Muskan Sain, Shital Rani, Suraj Pratap Singh, Pritiman Pothal, Shubham Yadav, Ashish Suttee, Akhilesh Kumar, Santosh Kumar, Pavitra Ranawat, Gurpal Singh, Ravi Pratap Barnwal. The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson’s Disease Pathogenesis. Molecular Neurobiology 2026; 63(1) doi: 10.1007/s12035-026-05917-6
|
| 458 |
Li Liu, Xiaodong Liu. Drug Transporters in Drug Disposition, Effects and Toxicity. Advances in Experimental Medicine and Biology 2019; 1141 doi: 10.1007/978-981-13-7647-4_9
|
| 459 |
Natalia Palacios, Katherine C. Hughes, Emanuele Cereda, Michael A. Schwarzschild, Alberto Ascherio. Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women. Movement Disorders 2018; 33(9) doi: 10.1002/mds.109
|
| 460 |
Xiaodong Yang, Yiwei Qian, Shaoqing Xu, Yanyan Song, Qin Xiao. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease. Frontiers in Aging Neuroscience 2018; 9 doi: 10.3389/fnagi.2017.00441
|
| 461 |
Xue Ma, Qiang Wang, Wei Yuan, Yuan Wang, Feng Zhou, Kaiwen Kang, Xiaopeng Tong, Zhibin Liu. Electroacupuncture Alleviates Neuroinflammation and Motor Dysfunction by Regulating Intestinal Barrier Function in a Mouse Model of Parkinson Disease. Journal of Neuropathology & Experimental Neurology 2021; 80(9) doi: 10.1093/jnen/nlab046
|
| 462 |
Zhongci Hang, Tong Lei, Zehua Zeng, Shanglin Cai, Wangyu Bi, Hongwu Du. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomedicine & Pharmacotherapy 2022; 145 doi: 10.1016/j.biopha.2021.112343
|
| 463 |
Hong‐Xia Fan, Shuo Sheng, Feng Zhang. New hope for Parkinson's disease treatment: Targeting gut microbiota. CNS Neuroscience & Therapeutics 2022; 28(11) doi: 10.1111/cns.13916
|
| 464 |
L. Sardelli, M. Campanile, L. Boeri, F. Donnaloja, F. Fanizza, S. Perottoni, P. Petrini, D. Albani, C. Giordano. A novel on-a-chip system with a 3D-bioinspired gut mucus suitable to investigate bacterial endotoxins dynamics. Materials Today Bio 2024; 24 doi: 10.1016/j.mtbio.2023.100898
|
| 465 |
Ruby Sound. Nutraceuticals in Brain Health and Beyond. 2021; doi: 10.1016/B978-0-12-820593-8.00013-6
|
| 466 |
Nidhi Singh, Veer Singh, Sachchida Nand Rai, Vishal Mishra, Emanuel Vamanu, Mohan P. Singh. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes. Biomedicine & Pharmacotherapy 2022; 156 doi: 10.1016/j.biopha.2022.113958
|
| 467 |
Xiaoge Sun, Manish Shukla, Wei Wang, Shengli Li. Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers. npj Biofilms and Microbiomes 2024; 10(1) doi: 10.1038/s41522-024-00610-9
|
| 468 |
Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Abdul Azis, Ryosuke Arauchi, Rostia Arianna Abdullah, Arata Oh-Nishi, Jun Horiguchi. Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial. Clinical Neuropharmacology 2018; 41(5) doi: 10.1097/WNF.0000000000000299
|
| 469 |
Xi‐Chen Wu, Yi‐Yue Dong, Yu‐Chen Ying, Ping Yin, Yue‐Lai Chen. Acupuncture: A Promising Non‐Pharmacological Approach to Parkinson's Disease Management. Brain and Behavior 2026; 16(4) doi: 10.1002/brb3.71438
|
| 470 |
Christina Kumpitsch, Kaisa Koskinen, Veronika Schöpf, Christine Moissl-Eichinger. The microbiome of the upper respiratory tract in health and disease. BMC Biology 2019; 17(1) doi: 10.1186/s12915-019-0703-z
|
| 471 |
Mohamed J. Saadh, Shahad Mohammed Dhiaa, Pooja Bansal, Hasan Khalid Dabis, Ashu Katyal, Vivek Saraswat, Azher Abdulmutaleb Ibrahim, Radi Usama Kadem, Mohammed Ubaid. The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis. Current Behavioral Neuroscience Reports 2025; 12(1) doi: 10.1007/s40473-024-00292-9
|
| 472 |
Hang Zhu, Guifen Xu. Electrochemical biosensors for dopamine. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120039
|
| 473 |
Ramdas Mane, Saurabh Kashid, Farhan Mazahir, Awesh Kumar Yadav. Microbiota-Gut-Brain Axis and CNS Disorders. 2025; doi: 10.1016/B978-0-443-21680-0.00019-5
|
| 474 |
Bojing Liu, Arvid Sjölander, Nancy L. Pedersen, Jonas F. Ludvigsson, Honglei Chen, Fang Fang, Karin Wirdefeldt. Irritable bowel syndrome and Parkinson’s disease risk: register-based studies. npj Parkinson's Disease 2021; 7(1) doi: 10.1038/s41531-020-00145-8
|
| 475 |
Agata Mulak, Magdalena Koszewicz, Magdalena Panek-Jeziorna, Ewa Koziorowska-Gawron, Sławomir Budrewicz. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease. Frontiers in Neuroscience 2019; 13 doi: 10.3389/fnins.2019.00992
|
| 476 |
Sara Carloni, Francesco Strati. Physical and Biological Barriers at the Interface Between the Gut Microbiome and the Immune System. The Microbiomes of Humans, Animals, Plants, and the Environment 2025; 5 doi: 10.1007/978-3-031-84065-4_4
|
| 477 |
Tsung-Hsun Hsieh, Chi-Wei Kuo, Kai-Hsuan Hsieh, Meng-Jyh Shieh, Chih-Wei Peng, Yen-Chien Chen, Ying-Ling Chang, Ying-Zu Huang, Chih-Chung Chen, Pi-Kai Chang, Kai-Yun Chen, Hsin-Yung Chen. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease. Brain Sciences 2020; 10(4) doi: 10.3390/brainsci10040206
|
| 478 |
Zeyu Bao, Zeyu Zhang, Guoyang Zhou, Anke Zhang, Anwen Shao, Feng Zhou. Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.871720
|
| 479 |
Dragos Mihaila, Jordan Donegan, Sarah Barns, Daria LaRocca, Qian Du, Danny Zheng, Michael Vidal, Christopher Neville, Richard Uhlig, Frank A. Middleton, Brenda A Wilson. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function. PLOS ONE 2019; 14(6) doi: 10.1371/journal.pone.0218252
|
| 480 |
Paula Perez-Pardo, Tessa Kliest, Hemraj B. Dodiya, Laus M. Broersen, Johan Garssen, Ali Keshavarzian, Aletta D. Kraneveld. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies. European Journal of Pharmacology 2017; 817 doi: 10.1016/j.ejphar.2017.05.042
|
| 481 |
Parisa Gazerani. Probiotics for Parkinson’s Disease. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174121
|
| 482 |
Chunmei Jiang, Guangning Li, Pengru Huang, Zhou Liu, Bin Zhao. The Gut Microbiota and Alzheimer’s Disease. Journal of Alzheimer's Disease 2017; 58(1) doi: 10.3233/JAD-161141
|
| 483 |
Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin. Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease. Journal of Parkinson's Disease 2021; 11(3) doi: 10.3233/JPD-212574
|
| 484 |
N.G. Zhukova, Z.F. Sayfitdinkhuzhaev, G.M. Israilova, O.Ya. Bustonov, N.A. Nasriddinova, O.V. Gaponova, I.A. Zhukova, A.Ya. Masenko. «Brain—gut—microbiome» axis in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry 2025; 125(11) doi: 10.17116/jnevro202512511218
|
| 485 |
D. I. Trukhan, N. V. Konshu, P. O. Mogilina. Comorbidity of inflammatory bowel diseases and Parkinson’s disease. Meditsinskiy sovet = Medical Council 2025; (5) doi: 10.21518/ms2025-170
|
| 486 |
Yaping Shao, Weidong Le. Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease. Molecular Neurodegeneration 2019; 14(1) doi: 10.1186/s13024-018-0304-2
|
| 487 |
Ali Rezaie, Satish S.C. Rao. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2023; doi: 10.1016/B978-0-443-13911-6.00015-3
|
| 488 |
Shiro Mawatari, Yasuhiro Sasuga, Tomomi Morisaki, Mika Okubo, Takako Emura, Takehiko Fujino. Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-019-57309-7
|
| 489 |
Yunxin Hu, Haoyue Wang, Yongkang Zhong, Yongqi Sun. Retrospective analysis of diet and gut microbiota diversity and clinical pharmacology outcomes in patients with Parkinsonism syndrome. Heliyon 2024; 10(21) doi: 10.1016/j.heliyon.2024.e38645
|
| 490 |
Ziying Jiang, Xinyu Wang, Haoqiang Zhang, Jian Yin, Peiqing Zhao, Qingqing Yin, Zhenfu Wang. Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites. MedComm 2023; 4(3) doi: 10.1002/mco2.268
|
| 491 |
Bushra Bashir, Shahbaz Alam, Nikhil Khandale, Devendra Birla, Sukriti Vishwas, Narendra Kumar Pandey, Gaurav Gupta, Keshav Raj Paudel, Harish Dureja, Puneet Kumar, Thakur Gurjeet Singh, Gowthamarajan Kuppusamy, Flavia C. Zacconi, Terezinha de Jesus Andreoli Pinto, Muralikrishnan Dhanasekaran, Monica Gulati, Kamal Dua, Sachin Kumar Singh. Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews 2024; 95 doi: 10.1016/j.arr.2024.102236
|
| 492 |
Md. Faysal, Mehrukh Zehravi, Md Al Amin, Safia Obaidur Rab, Patibandla Jahnavi, Uppuluri Varuna Naga Venkata Arjun, Jeetendra Kumar Gupta, Abdul Ajeed Mohathasim Billah, Rajeshwar Vodeti, P. Dharani Prasad, Sultan Saeed Sultan Aseri, Falak A. Siddiqui, Talha Bin Emran. Clinical insights into the mechanisms of infectious microbes and microbiota in chronic neurologic and psychiatric diseases. Pathology - Research and Practice 2025; 272 doi: 10.1016/j.prp.2025.156090
|
| 493 |
Yongtao He, Jiayin Zhao, Hongtian Dong, Xiaoshuang Zhang, Yufei Duan, Yuanyuan Ma, Mei Yu, Jian Fei, Fang Huang. TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice. Life Sciences 2023; 333 doi: 10.1016/j.lfs.2023.122171
|
| 494 |
Gizem Özata UYAR, Hilal YILDIRAN. A nutritional approach to microbiota in Parkinson’s disease. Bioscience of Microbiota, Food and Health 2019; 38(4) doi: 10.12938/bmfh.19-002
|
| 495 |
Mozi Chen, Yiyao Dong, Jie Zheng, Yan Lin, Qiyao Li, Chuhua Wei, Linpei Zhuo, Yan He, Jing Sun, Feng Fu, Jiaming Liu. Trigonelline Alleviates Neuroinflammation in AAV‐SynA53T Parkinson's Disease Model Mice: Involvement of PI3K/AKT–NF‐κB Signaling and Gut Microbial‐Metabolic Remodeling. Food Science & Nutrition 2026; 14(10) doi: 10.1002/fsn3.72451
|
| 496 |
Kathleen Shannon, Pieter Vanden Berghe. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell and Tissue Research 2018; 373(1) doi: 10.1007/s00441-018-2856-4
|
| 497 |
Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis. Acta Pharmaceutica Sinica B 2021; 11(9) doi: 10.1016/j.apsb.2021.03.020
|
| 498 |
Urdhva Raval, Joyce M. Harary, Emma Zeng, Giulio M. Pasinetti. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders. Expert Review of Neurotherapeutics 2020; 20(7) doi: 10.1080/14737175.2020.1775585
|
| 499 |
Xiao-Li Dong, Xiong Wang, Fang Liu, Xin Liu, Zhong-Rui Du, Robert.W. Li, Chang-Hu Xue, Ka-Hing Wong, Wing-Tak Wong, Qing Zhao, Qing-Juan Tang. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. International Journal of Biological Macromolecules 2020; 164 doi: 10.1016/j.ijbiomac.2020.07.180
|
| 500 |
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare. The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease. Cellular and Molecular Neurobiology 2022; 42(2) doi: 10.1007/s10571-021-01066-7
|
| 501 |
Ilaria Cova, Alberto Priori. Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?. Journal of Neural Transmission 2018; 125(10) doi: 10.1007/s00702-018-1910-4
|
| 502 |
Manuele Biazzo, Manuela Allegra, Gabriele Deidda. Clostridioides difficile and neurological disorders: New perspectives. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.946601
|
| 503 |
Arshilin Philip Mani, Balamuralikrishnan Balasubramanian, Linsha A. Mali, Kadanthottu Sebastian Joseph, Arun Meyyazhagan, Manikantan Pappuswamy, Biljo V. Joseph. The Role of the Gut Microbiota in Neurodegenerative Diseases. Microbiology Research 2024; 15(2) doi: 10.3390/microbiolres15020033
|
| 504 |
Roberta J. Ward, David T. Dexter, Antonio Martin-Bastida, Robert R. Crichton. Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?. International Journal of Molecular Sciences 2021; 22(7) doi: 10.3390/ijms22073338
|
| 505 |
Eamonn M. M. Quigley. What can we learn from other clinical settings on the influence of the gut microbiome on the brain?. Clinical Liver Disease 2017; 9(2) doi: 10.1002/cld.614
|
| 506 |
|
| 507 |
Yogesh Singh, Christoph Trautwein, Achal Dhariwal, Madhuri S. Salker, Md Alauddin, Laimdota Zizmare, Lisann Pelzl, Martina Feger, Jakob Admard, Nicolas Casadei, Michael Föller, Vivek Pachauri, David S. Park, Tak W. Mak, Julia-Stefanie Frick, Diethelm Wallwiener, Sara Y. Brucker, Florian Lang, Olaf Riess. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72903-w
|
| 508 |
Aaron Lerner, Sandra Neidhöfer, Torsten Matthias. The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists. Microorganisms 2017; 5(4) doi: 10.3390/microorganisms5040066
|
| 509 |
Rosita Gabbianelli, Elisabetta Damiani. Epigenetics and neurodegeneration: role of early-life nutrition. The Journal of Nutritional Biochemistry 2018; 57 doi: 10.1016/j.jnutbio.2018.01.014
|
| 510 |
Marthinus Janse van Vuuren, Theodore Albertus Nell, Jonathan Ambrose Carr, Douglas B. Kell, Etheresia Pretorius. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease. Biomolecules 2020; 11(1) doi: 10.3390/biom11010030
|
| 511 |
Ruixue Huang. Gut Microbiota: A Key Regulator in the Effects of Environmental Hazards on Modulates Insulin Resistance. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.800432
|
| 512 |
Jessica Fessler, Vyara Matson, Thomas F. Gajewski. Exploring the emerging role of the microbiome in cancer immunotherapy. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0574-4
|
| 513 |
Aeja Jackson, Christopher B. Forsyth, Maliha Shaikh, Robin M. Voigt, Phillip A. Engen, Vivian Ramirez, Ali Keshavarzian. Diet in Parkinson's Disease: Critical Role for the Microbiome. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.01245
|
| 514 |
Qiaoyu Sun, Lu Cheng, Xiaoxiong Zeng, Xin Zhang, Zufang Wu, Peifang Weng. The modulatory effect of plant polysaccharides on gut flora and the implication for neurodegenerative diseases from the perspective of the microbiota-gut-brain axis. International Journal of Biological Macromolecules 2020; 164 doi: 10.1016/j.ijbiomac.2020.07.208
|
| 515 |
Jing Sun, Zongxin Ling, Fangyan Wang, Wenqian Chen, Haixiao Li, Jiangtao Jin, Huiqing Zhang, Mengqi Pang, Junjie Yu, Jiaming Liu. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neuroscience Letters 2016; 613 doi: 10.1016/j.neulet.2015.12.047
|
| 516 |
LOW-GRADE INFLAMMATION IN MODERN CIVILIZATION DISEASES: A NARRATIVE REVIEW OF MECHANISMS, BIOMARKERS, AND CLINICAL IMPLICATIONS. International Journal of Innovative Technologies in Social Science 2025; 5(4(48)) doi: 10.31435/ijitss.4(48).2025.4444
|
| 517 |
Liang Shen. Gut, oral and nasal microbiota and Parkinson’s disease. Microbial Cell Factories 2020; 19(1) doi: 10.1186/s12934-020-01313-4
|
| 518 |
Emily M. Klann, Upuli Dissanayake, Anjela Gurrala, Matthew Farrer, Aparna Wagle Shukla, Adolfo Ramirez-Zamora, Volker Mai, Vinata Vedam-Mai. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Frontiers in Aging Neuroscience 2022; 13 doi: 10.3389/fnagi.2021.782082
|
| 519 |
Xiao Wang, Min Wu. Research progress of gut microbiota and frailty syndrome. Open Medicine 2021; 16(1) doi: 10.1515/med-2021-0364
|
| 520 |
Myat Noe Han, David I. Finkelstein, Rachel M. McQuade, Shanti Diwakarla. Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. Journal of Personalized Medicine 2022; 12(2) doi: 10.3390/jpm12020144
|
| 521 |
Jonathan Timpka, Per Odin. Autonomic Dysfunction in Parkinson's Disease. International Review of Movement Disorders 2021; 1 doi: 10.1016/bs.irmvd.2021.07.004
|
| 522 |
Cassandra Francella, Jane A. Foster. Burger's Medicinal Chemistry and Drug Discovery. 2021; doi: 10.1002/0471266949.bmc297
|